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The crystal growth process and associated kinetics of two active pharmaceutical ingredients 
(API) has been investigated using three crystal growth methods. The impact of organic solvent, 
supersaturation, temperature, polymorph form, and crystal seed quality on the crystal growth 
was studied. Isothermal seeded desuperaturation (ISD) growth method was used to investigate 
the growth rate of multiple salicylamide (SAM) crystals simultaneously. In-situ fourier 
transform infrared (FTIR) spectroscopy probe was employed for the determination of solution 
concentration and supersaturation decay data obtained was modelled using several growth rate 
equations and growth models, also tested different representations of the driving force. ISD 
provides kinetic data which was statistically representative of the crystal population due to the 
large number of crystals studied. Measuring the interfacial angle between faces combined with 
preferred orientation X-ray diffraction (XRD) was found to be the most accurate and reliable 
method leading to successful identification of each predicted SAM crystal face. Cuvette (CV) 
growth method was used to study the growth of single SAM crystals and the crystal growth 
rates were measured for both primary nucleated crystals and seed crystals manually inserted 
into the cuvette. As each facet had been face indexed it allowed for the growth of specific 
crystal facets, i.e. (200) of SAM, to be extracted directly from single crystals using a 
microscope. In an attempt to study multiple single crystals at once under controlled 
hydrodynamics, crystal seeds were grown using a new approach called the rotating disk (RD) 
growth method. Wherein seed crystals were attached to a disk that was rotated in a 
supersaturated solution by which the diffusion resistance was found to be eliminated. RD 
method was used to study the growth of two APIs including SAM and FII & FIII polymorphs 
of piracetam (PCM). It was deduced that ethyl acetate was adsorbed more strongly on the faces 
of SAM than the other solvents tested, the increased size of which, explained the irregular 
hexagonal plate habit obtained and relatively slow growth rates. Growth rate of the (011) facet 
of piracetam FII and FIII crystals was found to be reduced in isopropanol also due to its 
stronger interaction. Metastable PCM FII was found to have faster growth rates than the 
thermodynamically stable FIII. Within the range of experimental conditions, the growth rates 
of SAM and PCM were strongly affected by the temperature and also supersaturation. With a 
10 °C increase resulting in a two to fourfold increase in the average growth rate depending on 
the solute – solvent system. Similarly, a two to fourfold increase in the average growth rate of 
both SAM and PCM was observed when the supersaturation was increased within the range of 
S-1 0.02 up to 0.10. Also SAM’s crystal seed quality was found to have a substantial impact 
on the growth rate, with rougher larger crystals leading to quicker growth due to the increased 
number of surface defects present which can act as attachment sites. Comparing the RD and 
CV growth rate data for SAM it indicated that the CV method led to growth rates which were 
controlled by the diffusion step. The growth order parameter determined in the ISD studies 
reveals a surface integration controlled growth process. Under similar conditions, both the RD 
and ISD methods produced comparable growth rates for SAM and also for PCM. Furthermore 
by examining the effect of the rotation speed on the crystal growth rates from RD method led 
to the finding that it was also surface integration controlled. The crystal growth rates of the 
(200) facet of SAM obtained via surface integration controlled growth resulted in 20 times 
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LIST OF SYMBOLS 
a Activity, dimensionless 
A BCF model parameter, K ms-1 
A Pre-exponential factor, m-3L-1 
Asurf Pre-exponential factor of surface diffusion 
equation, m2s-1 
B BCF model parameter, K2 
Bstep  Two-dimensional nucleation rate 
C  B&S model parameter, ms-1 
CV Crystal volume, m3 
D  B&S model parameter, K2 
Dsurf  Surface diffusion   coefficient, m2s-1 
dm/dt  Rate of increase of the linear dimension  
Ea  Apparent activation energy,  
kJmol-1 
Easurf activation energy of surface diffusion of 
adsorbed molecules, kJmol-1 
g Growth rate order, dimensionless 
G  Growth rate of a characteristic dimension 
of crystal, ms-1 or µms-1 
Gn Estimated growth rate of nucleation, ms-1 
h Height of the growth step, nm 
J Rate of homogeneous nucleation, m-3  
k Boltzmann constant, JK-1 or  
m2kgs-2k-1  
ka Surface area shape factor, dimensionless 
kg  Parameter in modified growth rate 
equation (pre-exponential factor/ 
frequency factor), unit depends on s term 
of the driving force 
kv Volumetric shape factor, dimensionless 
L Characteristic dimension of crystal, m 
M Molecular weight, gmol-1 
MD Mass deposition rates per unit surface 
area, kgm-2s-1 
NA Avogadro’s number 
Nt Total number of seed crystals, 
dimensionless 
P(t) Probability to detect crystals at time t, 
dimensionless 
R Gas constant, JK-1mol-1 
s Driving force, unit changes with 
representation 
S  Supersaturation ratio, dimensionless 
SA  Surface area, m2 
S-1 Relative supersaturation, dimensionless 
t  Time, s 
tg Growth time, s 
T  Temperature, K 
V Volume of solution, m3 
Vm  Molecular volume, m3 
νstep  Step advancement rate in the B+S model 
x  Mole fraction concentration, 
dimensionless 
xs          Mean   diffusion   distance   on   the  
                surface,  m 
 
Greek Letters 
β’ Correction factor, dimensionless 
∆G Gibbs free energy, kJmol-1  
γ  Activity coefficient, dimensionless 





 adsorbed   molecules, molecules/m2 
µ  Chemical potential, Jmol-1 
∆µ  Chemical potential difference, Jmol-1 
∆µT  Chemical potential difference, neglecting 
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Centre 
CG  Crystal Growth 
CNT  Classical Nucleation Theory 
CV   Cuvette growth method 
DIOX  1,4-dioxane 
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EtOH  Ethanol 
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MeCN  Acetonitrile 
MeOH  Methanol 
MSZW  Metastable Zone Width 
PAT  Process analytical technology 
PCM  Piracetam 
PTFE  Polytetrafluoroethylene 
P-XRD  Powder X-Ray Diffraction 
RD  Rotating disk growth method 
SA  Salicylic acid 
SAM  Salicylamide 
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 Context of Research  
Crystallisation is one of the oldest separation and purification unit operations, and arguably the 
most important operation in the chemical industry [1-3]. Crystallisation is the process of 
formation of solid crystals from solution, melt or by deposition directly from a gas phase [3, 
4]. Crystallisation from solution is a very important technique especially in the pharmaceutical 
sector, as it is used in the formation, purification and recovery of crystalline active 
pharmaceutical ingredients (API) [2, 4, 5]. It is a complicated processes unique for each 
substance and which can also vary with respect to the process conditions used e.g. 
concentration, temperature, solvent, and agitation etc. [3]. This process gives rise to the solid 
state properties of the crystal which play a part in both the downstream processing e.g. 
filtration, washing and drying and the end-use properties like tableting and dissolution rate [3, 
6].  
Over the past several decades there has been an increased demand to be able to control the 
crystallisation process as requested by both the pharmaceutical industry and also to satisfy the 
regulatory authorities [1, 2, 7]. With the goal of being able to consistently manufacture active 
pharmaceutical ingredients (APIs) of high and reproducible quality combined with the desired 
solid state properties [7]. In order to be able to control this process and isolate crystals with 
required purity, size, shape and polymorph, a better fundamental understanding of the 
mechanisms and phenomena involved in crystallisation is required [2, 6, 8, 9]. Presently, 
crystallisation fundamentals are still insufficiently understood which results in industrial 
crystallization processes mainly being developed by trial and error experiments. Computational 
and molecular dynamics simulations have started to be used to try predict the crystal habit 
grown in solvent and are beginning to show interesting findings which are matching to 
experimental work [10-15]. Unfortunately, these methods are only being used for rather simple 
compounds as we can't provide the models with adequate kinetics of nucleation and crystal 
growth. More research needs to be done in this area before it is possible to be able to fully 
predict the crystallisation of complex API, under a range of process conditions.  
Crystallisation is a two-step process; initial nucleation followed by subsequent crystal growth. 
Efforts have previously been made to understand the process and kinetics of nucleation [16-
30]. Presently, the crystal growth kinetics data can differ by an order of magnitude for the same 




reproducibility from batch to batch this variance in crystal growth is undesirable. Literature 
describes a number of methods which allow for the observation of the crystal growth process 
and associated growth rates to be measured [9, 31-41]. These methods can be largely split into 
single crystal growth and multiple crystal growth experiments. The single crystal growth 
experiments offer the advantage of observing the growth of specific crystals which allows for 
a fundamental examination of the growth process [31, 33, 38, 39, 42, 43]. On the other hand 
the multiple crystal growth method usually involves growing thousands of crystals at once in 
a batch reactor and uses process analytical technology (PAT) to detect growth within the 
system. Accordingly, the two methods have different merits and drawbacks and complement 
one another. 
Furthermore, the effect of a number of process conditions such as mixing, temperature, solvent, 
and supersaturation on the crystal growth process has also been investigated previously [1, 2, 
4, 5, 7, 9, 44-47]. Though there is still more research to be done in this section as it is still far 
from being predictable, in particular work needs to be focused on understanding the solvent 
effect on the growth step at a molecular level. Additionally, the API molecules are 
progressively becoming more complex due to different polymorph forms available which leads 
to increased difficulties to crystallize the material. So far research has been focused on 
understanding how polymorphism effects the nucleation stage [6–9], with little understanding 
of how different crystal polymorphs grow.   
 Aims of PhD 
The initial objective of this work was to rationalise the crystal growth process, in particular the 
associated kinetics, of active pharmaceutical ingredients. The crystal growth of two organic 
compounds was investigated; including a complex organic compound with two polymorphs. 
Both single crystal growth and multiple crystal growth methods were used to investigate the 
growth process at a fundamental and also statistically relevant level. The single crystal growth 
methods initially used crystals which were formed by spontaneous nucleation in a stagnant 
solution from which the effect of seeds and agitation on the crystal growth process and kinetics 
could be investigated. Precise face indexing of experimentally grown crystals using a 
combination of experimental and prediction techniques was carried out in order to be able to 
measure the crystal growth of a specific crystal facet using an optical microscope. The multiple 
crystal growth method was used to give a good insight into the overall crystal growth kinetics 




technology was utilised to record the growth within this batch reactor. Data was fitted to known 
empirical relationships and evaluated against current model theories. Additionally, an 
alternative crystal growth method has been developed which can combine the advantages of 
the single and multiple crystal growth methods into one experimental approach. An in-depth 
evaluation of the effect of several process conditions on the crystal growth was performed 
including solvent, supersaturation and temperature. Scanning electron microscopy was utilised 
to identify the growth features present on the crystal surface, in particular to distinguish any 
differences between surfaces when the crystal was grown in different solvents. Molecular 
modelling was used to support the experimental work. In particular, it was used to predict the 
crystal habit, examine the surface chemistry of different faces, and determine attachment 
energies of these faces. Also, it was used to quantify the adsorption energy of the various 
solvent molecules onto the crystal surface with an aim of providing insight into the solvent-
solute interactions involved in the growth.   
 Thesis Chapter Outline 
This thesis has been prepared in two sections. The first part of the thesis outlines the 
justification for the research, background on the research topic, the main experiments carried 
out, results obtained and conclusions drawn. The second part includes the journal publications 
associated with the work. These include additional results information, mainly molecular 
modelling which was utilised to compliment the experimental findings and was carried out by 
Vivek Verma and Jacek Zeglinski. Also includes SC-XRD data which was used to check unit 
cell data to ensure no new polymorphs and was carried out by Pauric Bannigan. Michael Svärd 
calculated the approximate representation of the activity coefficient ratios for a better 
estimation of the true driving force. Lijun Jia compiled the matlab script for fitting the growth 





 References for Chapter 1 
1. Gao, Z., et al., Recent Developments in the Crystallization Process: Toward the 
Pharmaceutical Industry. Engineering, 2017. 3(3): p. 343-353. 
2. Paul, E.L., ; Tung, H.-H,; Midler, M., Organic crystallization processes. Powder 
Technol., 2005. 150(2): p. 133-143. 
3. Rasmuson, Å.C., Introduction to Crystallization of Fine Chemicals and 
Pharmaceuticals, in Molecules: Nucleation, Aggregation and Crystallization. p. 145-
172. 
4. Lacmann, R., Crystallization, Third Edition. J. W. MULLIN, Butterworth-Heinemann, 
Oxford 1997, 527 Seiten, zahlr. Abb. und ISBN 0-7506-3759-5. Chemie Ingenieur 
Technik, 1998. 70(11): p. 1468-1468. 
5. Chen, J., ; Sarma, B.; Evans, J. M. B.,; Myerson, A. S., Pharmaceutical Crystallization. 
Cryst. Growth Des., 2011. 11(4): p. 887-895. 
6. Watterson, S., et al., Thermodynamics of fenofibrate and solubility in pure organic 
solvents. Fluid Phase Equilibria, 2014. 367: p. 143-150. 
7. Tung, H.-H., Industrial Perspectives of Pharmaceutical Crystallization. Org. Process 
Res. & Dev, 2013. 17(3): p. 445-454. 
8. Lee, A.Y. and A.S. Myerson, Particle Engineering: Fundamentals of Particle 
Formation and Crystal Growth. MRS Bulletin, 2006. 31(11): p. 881-886. 
9. Nguyen, T.T.H.H., R. B.; Roberts, K. J.; Marziano, I.; Nichols, G., Precision 
measurement of the growth rate and mechanism of ibuprofen {001} and {011} as a 
function of crystallization environment. CrystEngComm, 2014. 16(21): p. 4568-4586. 
10. Shi, W., et al., Solvent effect on the crystal morphology of 2,6-diamino-3,5-
dinitropyridine-1-oxide: A molecular dynamics simulation study. Journal of Molecular 
Graphics and Modelling, 2014. 50: p. 71-77. 
11. Wang, Y. and Z. Liang, Solvent effects on the crystal growth structure and morphology 
of the pharmaceutical dirithromycin. Journal of Crystal Growth, 2017. 480: p. 18-27. 
12. Wang, C., et al., Effects of solvent and supersaturation on crystal morphology of 
cefaclor dihydrate: a combined experimental and computer simulation study. 
CrystEngComm, 2016. 18(47): p. 9085-9094. 
13. Chen, J. and B.L. Trout, Computational Study of Solvent Effects on the Molecular Self-
Assembly of Tetrolic Acid in Solution and Implications for the Polymorph Formed from 
Crystallization. The Journal of Physical Chemistry B, 2008. 112(26): p. 7794-7802. 
14. Chen, G., et al., A study of the solvent effect on the crystal morphology of hexogen by 
means of molecular dynamics simulations. RSC Advances, 2015. 5(32): p. 25581-
25589. 
15. Tilbury, C.J., et al., Predicting the Effect of Solvent on the Crystal Habit of Small 
Organic Molecules. Crystal Growth & Design, 2016. 16(5): p. 2590-2604. 
16. Verma, V., et al., Dependence of Heterogeneous Nucleation on Hydrogen Bonding 
Lifetime and Complementarity. Crystal Growth & Design, 2018. 18(11): p. 7158-7172. 
17. Arribas Bueno, R., et al., Influence of Process Parameters on the Heterogeneous 
Nucleation of Active Pharmaceutical Ingredients onto Excipients. Organic Process 
Research & Development, 2017. 21(4): p. 559-570. 
18. Mealey, D., et al., Influence of solvent on crystal nucleation of risperidone. Faraday 
Discussions, 2015. 179(0): p. 309-328. 
19. Mealey, D., D.M. Croker, and A.C. Rasmuson, Crystal nucleation of salicylic acid in 




20. Kuhs, M., J. Zeglinski, and Å.C. Rasmuson, Influence of History of Solution in Crystal 
Nucleation of Fenoxycarb: Kinetics and Mechanisms. Crystal Growth & Design, 2014. 
14(3): p. 905-915. 
21. Liu, J., M. Svärd, and Å.C. Rasmuson, Influence of Agitation and Fluid Shear on 
Nucleation of m-Hydroxybenzoic Acid Polymorphs. Crystal Growth & Design, 2014. 
14(11): p. 5521-5531. 
22. Sudha, C. and K. Srinivasan, Nucleation control and separation of paracetamol 
polymorphs through swift cooling crystallization process. Journal of Crystal Growth, 
2014. 401: p. 248-251. 
23. Khamar, D., et al., Investigating the Role of Solvent–Solute Interaction in Crystal 
Nucleation of Salicylic Acid from Organic Solvents. Journal of the American Chemical 
Society, 2014. 136(33): p. 11664-11673. 
24. Kulkarni, S.A., et al., Crystal Nucleation Kinetics from Induction Times and Metastable 
Zone Widths. Crystal Growth & Design, 2013. 13(6): p. 2435-2440. 
25. Nordstrom, F.L., M. Svard, and A.C. Rasmuson, Primary nucleation of salicylamide: 
the influence of process conditions and solvent on the metastable zone width. 
CrystEngComm, 2013. 15(36): p. 7285-7297. 
26. Yang, H. and Å.C. Rasmuson, Nucleation of Butyl Paraben in Different Solvents. 
Crystal Growth & Design, 2013. 13(10): p. 4226-4238. 
27. Schreiber, R.E., et al., Real-time molecular scale observation of crystal formation. Nat 
Chem, 2017. 9(4): p. 369-373. 
28. Svärd, M.D., R. K.; Khamar, D.; Mealey, D.; Cheuk, D.; Zeglinski, J.; Rasmuson, Å. 
C., Solute clustering in undersaturated solutions – systematic dependence on time, 
temperature and concentration. Phys Chem Chem Phys, 2018. 20(22): p. 15550-15559. 
29. Davey, R.J., S.L.M. Schroeder, and J.H. ter Horst, Nucleation of Organic Crystals—A 
Molecular Perspective. Angewandte Chemie International Edition, 2013. 52(8): p. 
2166-2179. 
30. Anwar, J., S. Khan, and L. Lindfors, Secondary Crystal Nucleation: Nuclei Breeding 
Factory Uncovered. Angewandte Chemie International Edition, 2015. 54(49): p. 
14681-14684. 
31. Wu, K., et al., Measurement of Crystal Face Specific Growth Kinetics. Crystal Growth 
& Design, 2016. 16(9): p. 4855-4868. 
32. Perry, A.R., M. Peruffo, and P.R. Unwin, Quantitative Plane-Resolved Crystal Growth 
and Dissolution Kinetics by Coupling In Situ Optical Microscopy and Diffusion 
Models: The Case of Salicylic Acid in Aqueous Solution. Crystal Growth & Design, 
2013. 13(2): p. 614-622. 
33. Cano, H., N. Gabas, and J.P. Canselier, Experimental study on the ibuprofen crystal 
growth morphology in solution. Journal of Crystal Growth, 2001. 224(3–4): p. 335-341. 
34. Land, T.A., J.J. De Yoreo, and J.D. Lee, An in-situ AFM investigation of canavalin 
crystallization kinetics. Surface Science, 1997. 384(1): p. 136-155. 
35. Kitamura, M. and K. Onuma, In Situ Observation of Growth Process of α-L-Glutamic 
Acid with Atomic Force Microscopy. Journal of Colloid and Interface Science, 2000. 
224(2): p. 311-316. 
36. Hottenhuis, M.H.J. and C.B. Lucasius, The influence of impurities on crystal growth; 
In situ observation of the {010} face of potassium hydrogen phthalate. Journal of 
Crystal Growth, 1986. 78(2): p. 379-388. 
37. Zhang, R., et al., Stereo imaging camera model for 3D shape reconstruction of complex 
crystals and estimation of facet growth kinetics. Chemical Engineering Science, 2017. 




38. Davey, R.J. and J.W. Mullin, Growth of the {100} faces of ammonium dihydrogen 
phosphate crystals in the presence of ionic species. Journal of Crystal Growth, 1974. 
26(1): p. 45-51. 
39. Li, L. and N. Rodríguez-Hornedo, Growth kinetics and mechanism of glycine crystals. 
Journal of Crystal Growth, 1992. 121(1): p. 33-38. 
40. Pfeiffer, H., Analytical Theory of the Growth of Crystal Faces. physica status solidi (a), 
1983. 79(2): p. 445-454. 
41. Borchert, C., et al., Image-Based in Situ Identification of Face Specific Crystal Growth 
Rates from Crystal Populations. Crystal Growth & Design, 2014. 14(3): p. 952-971. 
42. Beckmann, W., Simultaneous measurement of the growth rates of the (001) and (110) 
faces of stearic acid growing from solution. Journal of Physics E: Scientific 
Instruments, 1986. 19(6): p. 444. 
43. Kitamura, M. and T. Ishizu, Growth kinetics and morphological change of polymorphs 
of L-glutamic acid. Journal of Crystal Growth, 2000. 209(1): p. 138-145. 
44. Sankaranarayanan, K. and P. Ramasamy, Unidirectional seeded single crystal growth 
from solution of benzophenone. Journal of Crystal Growth, 2005. 280(3–4): p. 467-473. 
45. El-Zhry El-Yafi, A.K. and H. El-Zein, Technical crystallization for application in 
pharmaceutical material engineering: Review article. Asian Journal of Pharmaceutical 
Sciences, 2015. 10(4): p. 283-291. 
46. Demazeau, G., Review. Solvothermal Processes: Definition, Key Factors Governing 
the Involved Chemical Reactions and New Trends, in Zeitschrift für Naturforschung B. 
2010. p. 999. 
47. Croker, D.M., ; Kelly, D. M,; Horgan, D. E,; Hodnett, B. K,; Lawrence, S. E,; 
Moynihan, H. A,; Rasmuson, Å. C., Demonstrating the Influence of Solvent Choice and 
Crystallization Conditions on Phenacetin Crystal Habit and Particle Size Distribution. 


























 Literature Review 
 The Solid State 
Molecular solids can exist in crystalline or noncrystalline (amorphous) phases depending on 
the three-dimensional order. Crystalline solids consist of regular repeating three-dimensional 
structures held together by uniform intermolecular forces to create a crystal lattice, whereas 
amorphous solids are not arranged in regular arrays. The smallest repeating unit within the 
crystalline solid is known as the unit cell and it is described using six lattice parameters; the 
three dimensions (a, b, c) and the three angles (α, β, γ). Based on these lattice parameters there 
are 14 possible point lattices which can be constructed. These point lattices can be split into 7 
crystal systems as shown in Figure 2.1. Within these systems, lattices can either be simple if 
they are primitive (one lattice point per unit cell) or body-centered / face-centered if they are 
non-primitive (more than one lattice point per unit cell). In order to define a plane within the 
crystal lattice a notation system known as miller indices is used. It is determined by three 
integers h, k, and l and are written in the form (hkl). The external appearance of the crystal is 
referred to as its habit which is controlled by the relative areas of the faces. Habit describes the 
crystal shape without reference to the crystal structure whereas crystal morphology describes 
the shape of the crystal structure [1]. Crystals with the same crystal lattice can have different 
habits depending on the growth conditions used, which is of course controlled by the diverse 
growth rates of each facet. The crystal habit gives rise to the solid state properties which play 
a part in both the downstream processing (e.g. filtration, washing and drying) and the end-use 
properties (e.g. tableting and dissolution rate) so it is vital to be able to control the crystal habit 
[2, 3]. 
 






Polymorphism is the ability of a compound to crystallize into two or more crystalline forms or 
crystal structures [4, 5]. In some literature, it has been reported that between 32% and up to 
51% of small organic molecules, which make up 90% of API used in pharmaceutical drugs, 
have polymorphs [5-7]. Different polymorphs can have different properties including 
solubility, dissolution rates (bioavailability), biological action, and stability [5, 8, 9]. 
Polymorphs are classified into one thermodynamically stable form with the rest being 
metastable. The stable polymorph has the lowest free energy, and so it will have the lowest 
solubility and therefore the lowest bioavailability [5, 8]. It is vital that the right polymorph with 
optimal properties is chosen during the design stage of the drug [5, 10-12]. There have been a 
number of well-known cases of pharmaceutical drugs which had to be withdrawn from the 
market due to new polymorph discovery; including Immunoprin (thalidomide), Norvir 
(ritonavir), and Neupro (rotigotine) [7, 9, 11, 13-15]. Due to these issues understanding the 
different polymorphs of each API, their properties and why they appear is of utmost importance 







Crystallisation may be defined as the process of formation of solid crystals from solution via a 
two-step process of nucleation and subsequent crystal growth [3-5, 16]. A homogenous 
solution can be made by the addition of a solid solute to a liquid solvent. The solubility of this 
solution is equal to the maximum amount of solute that can dissolve in a given amount of 
solvent at a given temperature and pressure. When the solution contains the maximum amount 
dissolved it is said to be saturated, i.e. the system is at equilibrium. In other words, the chemical 
potential of the solute in the solution is the same as the chemical potential of the species in the 
solid phase. Solubility is known to vary widely for different materials, due in part to their 
different solute and solvent interactions. Also the solubility depends on the temperature, for 
most material solubility increases with temperature [17]. An example of a solubility curve for 
a solute in a solvent is shown in Figure 2.2. The solubility line defines the saturation level, with 
the region below the line describing an unsaturated solution and the region above referring to 
a supersaturated solution. A supersaturated solution is one that contains excess solute than can 
normally be dissolved at its equilibrium solubility. This metastable state can be created by 
cooling a saturated solution as illustrated in Figure 2.2 by the black circles labelled x and x* 
respectively, or else by evaporation of the solvent or changing the solvent composition etc. 
[18]. In order for the supersaturated solution to move towards equilibrium, the excess solute 
crystallises. The supersaturation region can be split into two sections; the area closest to the 
saturation line is a region in which only crystal growth will typically occur and the area above 
this is the region where both nucleation and crystal growth can occur, see Figure 2.2. The 
crystal growth region is commonly referred to as the metastable zone width (MSZW). MSZW 
is a practical property, which is of significant industrial importance as it provides a working 
region for crystal growth to be performed without unwanted nucleation. The width of the 
metastable zone can be altered by a number of factors e.g. solution history, cooling rate, 














Figure 2.2. This graph shows the solubility curve of a solute in a solvent, below which the 
region is unsaturated. The metastable zone width limit is the region just above the solubility 
line which is slightly supersaturated and mostly only growth occurs here. The region above 
the MSZW is highly supersaturated and is where both nucleation and growth occurs. Points 
indicated using black circles on the graph refer to saturated, x*, and supersaturated, x, states 
brought about through cooling. 
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The true thermodynamic driving force for crystallization, Δμ (J mol-1), is the difference in the 
chemical potential between the solute in the supersaturated solution and in the corresponding 









        (1) 
This expression is commonly simplified by neglecting the activity coefficient ratio entirely, 
and is often represented simply by a concentration ratio, S, or by using eq 2 as being an 






            (2) 
In a recently proposed method, an approximate representation of the activity coefficient ratio 
is obtained by neglecting only the temperature dependence, but not the concentration 
dependence, of the activity coefficient [19], resulting in the expression for the driving force 












     (3) 
where γ for the supersaturated solution has been replaced by the corresponding value for the 
solution at its saturation temperature. For solutions that are not too dilute, i.e. in the Henry’s 
law region, this method is expected to be more accurate than neglecting the activity coefficient 





 Nucleation  
Nucleation is a phase separation and refers to the formation of a nuclei or critical cluster; small 
entities having crystalline structure [3-5, 20]. Nucleation can be classified into either primary 
or secondary nucleation. Primary nucleation is when no crystals are present in the starting 
solution whereas secondary nucleation is when solute crystals are present in the starting 
solution to induce nucleation. Primary nucleation is further divided into homogeneous 
nucleation, occurs spontaneously in bulk solutions, or heterogeneous nucleation, induced by 
foreign particles [3, 5, 21, 22].  
Classical nucleation theory (CNT) is the most common theoretical model used worldwide to 
understand the kinetics of homogeneous nucleation [20]. CNT presumes that before nuclei are 
observed, initial clusters are formed in solution which have the same structure as the final 
crystalline material [23, 24]. Once the cluster reaches the critical size it becomes 
thermodynamically stable, and will form a nuclei provided the free energy gain of forming the 
crystalline material overcomes the free energy cost of creating the phase boundary. CNT uses 
an Arrhenius-type equation, eq. 4, to express the rate of nucleation i.e. the number of nuclei 
formed per unit time per unit volume [21, 25]: 
𝐽 = 𝐴 𝑒𝑥𝑝 (
−∆𝐺∗
𝑘𝑇
)        (4) 
A is a pre-exponential factor that has a theoretical value of 1030 nuclei per cm3 per s [26]. The 
thermodynamic considerations, ΔG’, take into account the free energy change for the formation 
of the nucleus surface and also the free energy change for the phase transformation and can be 
described by the following, eq.5, assuming a spherical nuclei:  
∆𝐺′ =  
16𝜋𝜎3𝑣2
3(𝑘𝑇𝑙𝑛𝑆)2
      (5) 
Fitting eq. 5 into eq. 4 it is clear to see that the nucleation rate would increase with increasing 
supersaturation and temperature, and decrease with an increase in surface energy. CNT is a 
rather analytically simplistic model which is based on a number of assumptions. It relies on the 
clusters being spherical droplets, also the growth of clusters is based on one unit at a time etc. 
In order to overcome these shortcomings, a two-step pathway known as ‘non-classical’ 
nucleation theory was proposed [26]. The first step of which involves a separation of a dense, 
disordered liquid phase which will then form a liquid like cluster and crystalline order will 




Nucleation is regarded as a stochastic phenomenon related to the random behaviour of the 
molecules in solution [23]. To account for this stochastic nature of nucleation, a number of 
probability distribution functions have been developed which can be fitted to experimental 
isothermal nucleation data. For example the Jiang and ter Horst probability distribution, eq. 6, 
which describes, under constant supersaturation, the probability of detecting crystals as a 
function of time, P(t), within an agitated solution [27]:  
𝑃(𝑡) = 1 − 𝑒𝑥𝑝(−𝐽𝑉(𝑡 − 𝑡𝑔))     (6) 
Where J is the stationary nucleation rate, V is the volume of solution, and the term (t- tg) is 
used to account for the delay in time of detecting a nuclei due to the fact that it has to grow to 





 Crystal Growth  
 Crystal Growth Process  
The crystal growth process outlines the steps taken by a growth unit (atoms, molecules, ions, 
hydrated solute molecules, dimers, clusters, etc.) as it’s incorporated into the crystal surface as 
illustrated in Figure 2.3. Crystals are thought to grow in a layer-by-layer fashion and the process 
is understood to be made up of the following steps [4, 18, 21, 28, 29]: 
1. Bulk Diffusion  
Transport of growth units through solution. 
 
2. Surface Integration  
a) Attachment of growth units to the surface. 
b) Movement of growth units on the surface. 
c) Attachment of growth units into the crystal lattice. 
These stages are essentially acting in series whereby the slowest one will be rate determining. 
Generally, diffusion governs the growth at high supersaturations and temperatures, whereas 
surface integration dominates at moderate supersaturations and temperatures. With increasing 
relative velocity between the crystals and the fluid the volume diffusion resistance decreases. 
The crystal growth rate increases and the crystal growth process becomes increasingly 
governed by the surface integration step. The integration rate is low when there is a perfectly 
flat surface, whereas this rate can increase when there are steps and kinks on the surface that 
provide favourable sites for integration as shown in Figure 2.3 [30]. 
 
Figure 2.3 Kossel’s model of a growing crystal surface showing flat surfaces (i), steps (ii), 
kinks (iii), edge vacancies (iv), surface-adsorbed growth units (v), and surface vacancies (vi) 





 Crystal Growth Mechanisms 
The growth rate of a crystal face is dependent on its underlying growth mechanism [4, 31]. 
Although these crystal faces appear flat to the naked eye, the crystalline surface is rarely so at 
the molecular level. The surfaces of crystal facets have been examined with scanning electron 
microscopy and atomic force microscopy which have shed light onto the possible growth 
structures and mechanisms, such as spiral, kinks, steps, layers, 2D nucleating islands etc. [32, 
33]. Crystal growth mechanisms have been discussed extensively throughout the literature, 
from initial concept stage [34] to implementation into current crystal growth studies [35]. 
Different mechanisms may be in operation depending on the conditions used such as 
supersaturation, temperature etc. Specifically for the surface integration step, two face growth 
rate models are commonly used.  
Burton, Cabrera and Frank (BCF) described the screw dislocation mechanism, eq. 7 [34, 36]. 
The BCF model involves a dislocation center which acts as a continuous source for generating 
spiral shaped surface steps [31, 32]. As there is a permanent supply, growth can continue at 
relatively low supersaturation. The rate of growth is determined by the propagation of these 
steps which in turn depends on the crystal surface and also the physical properties of the crystal 
growth system, elements of which are taken into account within parameter A (eq. 8) and 
parameter B (eq. 9) respectively. Parameter A is here treated as temperature-dependent, Г* is 
the solute molecular adsorption coverage, Dsurf is the surface diffusion coefficient, Vm is the 
molecular volume of the solute, xs is the diffusion mean free path over the surface. Parameter 
B is considered independent of temperature in this work and it too includes the terms Vm and 
xs, it also incorporates γsl the solid-liquid interfacial energy and k the Boltzmann constant. The 
interfacial energy occurs in the equation as a transformation of the edge energy of the growth 
step. The edge energy determines the radius of the critical two-dimensional nucleus that 
determines the radius of the Archimedes spiral describing the screw dislocation. The higher the 
edge energy the greater the distance between two nearby steps, and the longer the average 
distance of surface diffusion becomes [35]. BCF model calculates crystal growth rates to vary 
from a parabolic dependence on supersaturation to a linear dependence as the supersaturation 
increases. The model predicts growth to depend on the step height, surface diffusion and 





The Spiral Growth model (BCF): 














tanhln1BCF                                (7) 
                  (8, 9)  
 
The birth and spread (B&S) growth mechanism, eq. 10, relies on crystal surface nucleation 
(birth), followed by the growth (spread) of the monolayers. B&S is likely to occur at higher 
supersaturations than the BCF mechanism as it requires a higher driving force to generate the 
two dimensional (2-D) surface nucleation. This surface nucleation can develop at any location 
on a crystal surface, e.g. edges, corners and on the faces. Further surface nuclei can absorb and 
integrate into the monolayer allowing it to spread across the crystal face [4]. Where h is the 
height of the growth step, Bstep denotes the rate of two-dimensional nucleation, and νstep is the 
rate of step advancement. The B&S model contains two parameters, C (eq. 11) and D (eq. 12), 
which describe very similar properties of the crystal growth system as their respective 
counterparts (A and B) in the BCF model. Also, analogous to the BCF model, C and D are 
considered to be temperature dependent and independent, respectively. The solid-liquid 
interfacial energy in the B&S model within parameter D (eq. 12) describes the radius of the 2D 
critical nuclei that form on the surface and are the source of new growth steps. B&S predicts 
that the growth rate of the crystal increases with increasing supersaturation and increasing 
temperature [17].  
The Birth and Spread model (B&S): 
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The two facet growth models contain parameters A and C, respectively, which both rely heavily 
on a Dsurf term, eq. 13. This is simply an Arrhenius equation with emphasis on the activation 














 Crystal Growth Methods   
Literature depicts many ways in which the crystal growth process can be observed and 
associated growth rates measured dependent on the crystal growth method used [31, 32, 39-
49]. These methods can primarily be split into two categories; single crystal growth or multiple 
crystal growth methods. The basic difference being that in the former method the direct growth 
rate of the individual crystal is recorded while in the latter the average growth rate of an 
ensemble of crystals is determined without distinguishing the growth of each individual crystal.  
The simplest version of the single crystal growth method involves observing the growth of one 
crystal in a stagnant solution. This approach was used in recent work by Nguyen studied the 
influence of solvent on the growth rate of ibuprofen crystal facets and overall crystal habit 
using a stagnant solution in a cuvette [31]. Such measurements are helpful in that they provide 
baseline crystal growth kinetic data from which the impact of e.g. seeds, agitation and mixing 
can be assessed subsequently. Since the 1970’s researches have made attempts at introducing 
mixing of the solution into single crystal growth experiments in order to control the 
hydrodynamics. The most successful was a simple closed flow cell combined with an optical 
microscope to observe the growth of the (100) face of ammonium dihydrogen phosphate 
crystals [46]. Since then this single crystal growth method using liquid flow has been used by 
many to study the growth rates of other compounds such as glycine, α and β polymorphs of L-
glutamic acid [40, 42, 47, 50, 51]. The issue with this flow design results in growth being 
unidirectional, so growth of the crystal is not representative of a true crystal. In addition, it 
becomes very tedious to obtain statistically valid data over a number of crystals due to the 
phenomenon of growth rate dispersion (GRD) whereby growth rates have been found to vary 
from crystal to crystal when grown within an identical system [31, 52]. Rotating disks have 
also been used a few times to study crystal growth in a mixed solution [53, 54]. However, they 
only studied the growth of one compressed crystal plane rather than a single crystal. In most 
cases, crystal growth rates of single crystals can be measured directly from microscopic images 
of the growing crystals taken at different time points. The growth rate in a specific direction, 
G (ms-1 or μms-1), can be represented by eq 14 [31].  
dt
dLG       (14) 
Where G is the rate of change of the crystal’s characteristic dimension, L, has dimensions of 




dimensions including the length & width (maximum and minimum feret diameter respectively) 
or else the specific crystal faces which make up these dimensions [52].   
Multiple crystal growth studies have been performed over the years both in academia and 
industry using a simple batch reactor design [55-61]. The supersaturation often has to be low 
to avoid nucleation, breakage or agglomeration, and the concentration decay has to be recorded 
with high accuracy. One of the most widely accepted approaches involving the batch reactor 
has been the isothermal seeded desupersaturation crystal growth method. It has been used to 
successfully determine the crystal growth rates for multiple crystals of a number of organic 
compounds including salicylic acid, paracetamol, ibuprofen etc. [29, 30, 35, 62-72]. Significant 
advances in the process analytical technology (PAT) available in recent years has allowed for 
more accurate estimations and control of the crystal growth rates obtained from these batch 
reactors. Crystal growth rates have successfully been determined by recording the solution 
concentration using in situ ATR-FTIR and Raman spectroscopy without calibration [73]. Often 
a simple empirical power law equation, eq 15, can be fitted to the desupersaturation data that 
is obtained in these growth experiments to relate the overall linear growth rate of the crystals 
to the supersaturation. It is known to correlate experimental data well over narrow 
supersaturation ranges. This equation can be modified to also include explicit temperature 
dependence on the rate constant in accordance with an Arrhenius-type equation as in eq 16. 
Simple Overall Growth Rate Equation:  
g
g(s) , where  = -1 or TG k s s S      (15) 
Modified Overall Growth Rate Equation:  
ga
g0(s) exp , where  = -1 or T
E






  (16) 
Where kg is an overall crystal growth rate constant, s is the measure of supersaturation and g is 
the growth rate order.  
An advantage of the single crystal growth methods is that the detailed growth in different 
directions and of different faces can be measured which is of fundamental interest as different 
facets of a crystal have been found to grow at different rates under identical environmental 




often far from those in a real crystallizer. Benefits of the multiple crystal growth methods is 
that a better statistical averaging can be obtained and the hydrodynamic conditions can 
resemble industrial conditions. Previous efforts have tried to combine the advantages of both 
the single and multiple crystal growth methods into one experimental approach by using an 
agitated batch crystalliser combined with a high speed camera. Using this methodology, it has 
been shown to be possible to measure the growth rates of either the length and width or facet 
direction for a number of individual crystals grown at once [49, 75, 76]. The disadvantage of 
this analysis is that the growth of a specific crystal can’t be tracked, rather results are averages 





 Factors Affecting Crystallisation  
Significant research has went into discovering the process conditions which can affect the 
crystallisation process, and in particular trying to understand each of their effects on a 
molecular level [22, 77]. The key factors can be divided into three main sub-groups: 
1. Molecular recognition (Chemical) 
 Seed 
 Solute-Solute Interactions 
 Solvent-Solute Interactions 
2. Thermodynamics (and or Physical) 
 Solvent  
 Solubility 
 Temperature 
 Hydrodynamics  
3. Kinetics 
 Supersaturation 
 Growth Rate 
 Metastable Zone Width 
From a molecular point of view, the crystal seed properties including its size and quality will 
ultimately have a large effect on the crystallisation process as they will dictate the roughness 
of the surface i.e. the number of attachment sites present to begin with. The solvent-solute 
interaction can cause different polymorphs to form [4, 15, 78-84]. A number of studies have 
focused on the nucleation step and the kinetics of the different polymorphs [6–9]. The effect 
of solvent on the formation of four polymorphic forms of sulfathiazole was examined with 
respect to the crystal facets of each. The results stated that there was “no obvious relationship 
between the appearance of a particular polymorph from solution and the growth of its fastest 
growing surface”, instead claiming the polymorph which formed was as a result of the 
nucleation stage [85]. However work with L-histidine polymorphs suggests that the crystal 
growth rate of form A controls the solution-mediated transformation of the polymorphs [86]. 
Additionally, the morphology and growth rates of two polymorphs of l-glutamic acid in a batch 




polymorph had faster growth rates than the stable β form [87]. Illustrating the importance of 
studying both the nucleation and crystal growth processes of different polymorphs in detail.  
Furthermore, solvent plays a key role in influencing both the nucleation and crystal growth 
processes [25, 29, 35, 60, 69, 72, 88-97]. Solvents may accelerate, impede or even inhibit the 
growth of specific crystal faces, which can lead to a change in the resulting habit [98, 99]. It is 
hypothesised that the solvent can increase the growth rate when it has favourable interaction 
with the solute and so reduces the interfacial tension which causes the crystal surface to alter 
from smooth to a rough interface. In an alternative theory, solvent is thought to preferential 
adsorb to specific faces and so will inhibit their growth as removal of the bound solvent poses 
an additional energy barrier for continued growth [100]. In keeping with the latter theory, polar 
solvents which had stronger interaction with phenacetin crystals have been found to create 
smaller crystals than when same solute was grown in aprotic solvents [101]. Solvent was also 
found to reduce the growth rate of the polar faces of α-resorcinol [92], succinic acids (001) face 
containing carboxylic acid groups [102], and also a number of polar crystals which had a high 
binding compatibility with a solvent and thus strong interaction [103]. To support these 
experimental approaches, computational and molecular dynamics simulations have been used 
to examine and try to understand the effect of solvent on the crystal growth process at a 
molecular level [104-107]. Similarly, the effect of additives on the crystal growth process of 
urea and ibuprofen has also been investigated [108, 109]. Despite these efforts, the effect of 
solvent is only recently beginning to be predicted for small simple organic molecules [110]. In 
order to be able to predict the crystal growth for large complex molecules in a range of solvents 
there is still a great amount of detail that needs to be understood about these interactions.  
As a simple rule-of-thumb the Arrhenius equation can be used to assess the effect of 
temperature on a reaction rate. It estimates that a 10 K increase in the temperature will result 
in the reaction rate doubling on the basis that the fraction of molecules with energies equal or 
in excess of the activation energy will double and the frequency factor will remain 
approximately constant for such a small temperature change. Crystal growth surfaces tend to 
be rougher at higher temperatures which also results in faster growth rates [48]. It has been 
found that at higher temperatures, thermal-induced grown-in-defects form [16]. Crystal growth 
of salicylic acid was investigated under a range of temperatures using a multiple crystal growth 
method and found that increasing the temperature led to an overall increase in crystal growth 




respectively [35]. For this reason temperature effect on growth still needs to be examined. 
Growth rates have also been found to increase with increasing supersaturation to different 
extents, again depending on the solvent type [31, 35]. Similar to the temperature effect, the 
overall effect of increasing solubility is a roughening of the surface and so results in a faster 
growth of the crystal facets [102], as also shown by [29, 54]. However, this has been proven to 
be overruled when the solvent-solute interaction are stronger [102]. The effect of surface 
roughness on the crystal growth rates has been investigated and found the rate to be partly 
controlled by the level of defects within the crystal [111]. Thus crystal seed quality will be play 
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 Materials & Experimental Methodology 
 Materials  
 Solvents 
Acetone (AC), acetonitrile (MeCN), 1,4-dioxane (DIOX), ethanol (EtOH), ethyl acetate (EA), 
isopropanol (IPrOH), and methanol (MeOH) were purchased from either Sigma Aldrich or 
Fisher Scientific. All solvents had a purity ≥ 99.7 % and used without further purification. These 
organic solvents were selected as they are commonly used in the pharmaceutical industry [1]. A 





























































































































































































































































































































































 Solutes (API) 
Salicylamide (SAM), C7H7NO2, is classified as a non-prescription drug with analgesic and 
antipyretic properties, and used as an over-the-counter pain remedy. SAM was purchased from 
Sigma Aldrich with ≥ 99.0 % purity and used without further purification. SAM is supplied as 
white, mainly blocky or plate-like crystals, with molecular weight 137.14 g mol-1, and melting 
point of 138.7 °C [3-5]. SAM has two polymorphs reported in the literature; FI and FII. FI, 
monoclinic, is the stable polymorph at ambient conditions whereas FII, orthorhombic, is only 
obtained under high pressure (>0.5 GPa) [4]. The single crystal structures for both of the 
polymorphs have already been determined, CIF files available [4, 6, 7]. The solubility of SAM 
FI in acetone, acetonitrile, ethyl acetate and methanol has been determined between 10 °C and 
50 °C [3].  
Piracetam (PCM), C6H10N2O2, is classified as a nootropic drug and is used to treat cognitive 
impairment. Piracetam was purchased from Baoji Guokang Bio-Technology with ≥ 99.0 % 
purity and used without further purification. PCM is supplied as white crystalline powder, with 
molecular weight 142.16 g mol-1, and melting point of 152.0 °C. PCM has five polymorphs 
reported in the literature; FI (6.747), FII (6.403), FIII (6.525), FIV (8.954) and FV (6.390) [8-
10]. For clarity of the nomenclature of the polymorphs, the α-lattice parameter of the crystal 
structure is included within the brackets. FI is only formed when either FII or FIII is heated above 
130 °C and quickly transforms back, FII is the metastable form, FIII is the stable form at ambient 
conditions, and FIV and FV are only obtained at high pressure (>0.5 GPa). The solubility and 
stability of PCM FII and FIII in ethanol and isopropanol has already been determined between 







Figure 3.1. Molecular structure of the active pharmaceutical ingredients of a) salicylamide and 





 Experimental Methodologies 
 Preparation & Characterisation of Crystal Seeds 
Crystal seeds were prepared using standard methodology as described in the literature [13, 14]. 
Both SAM and PCM were supplied in the form of crystalline powder and so were characterized 
by optical microscopy (Olympus IX53) and P-XRD (PANalytical-Empyrean X-ray 
Diffractometer) to check their polymorphic form. P-XRD data was collected in reflectance mode 
with an Empyrean diffractometer (PANalytical, Phillips) equipped with CuKα1,2 radiation (γ = 
1.5406 Å) operating at 40 kV and 40 mA at room temperature. Samples were scanned between 
2θ values of 5 and 50° at a step size of 0.079° 2θ/s, 90.27s per step. The experimental P-XRD 
patterns were compared with reference P-XRD diffractograms for SAM and PCM polymorphs 
which were obtained from the Cambridge Crystallographic Data Centre (CCDC) using the 
software Mercury 3.9 and compared with Highscore Plus. SAM was comprised of the required 
pure FI (matched with SALMID01) whereas PCM was comprised of impure FIII (matched with 
BISMEV01). In order to obtain pure PCM crystals with the required polymorphic forms the 
material supplied was recrystallized. PCM FII and FIII polymorphs were formed in DIOX and 
MeOH respectively using a cooling crystallisation method [10, 11]. Once more, P-XRD was 
used to confirm the polymorphic identity. SAM FI, PCM FII, and PCM FIII crystals were then 
sieved using fisherbrand stainless steel woven wire mesh test sieve with square apertures of 
nominal sizes 100-180 µm, 180-250 µm and 250-400 µm or 250-300 µm and 300-355 µm. These 
sieve fractions were used as the seed crystals in the subsequent growth experiments.  
SAM crystals were also grown via a slow solvent evaporation crystallisation method under 
controlled room temperature from initially saturated solutions. Saturated solutions were prepared 
by dissolving sufficient amount of SAM in four solvents (AC, MeCN, EA and MeOH), and left 
mixing at 19 °C (room temperature) for 1 hour. 10 mL of solution was filtered and poured into 
new vial of width 27.5 mm and covered with parafilm with 3 pin holes with diameter 1.2 mm to 
control evaporation. Vials were left for 1 week to allow crystals to form, in the fastest system 
crystals appeared in two days. Crystals which formed in each of the solvents were used in the 
subsequent face indexing study.  
The surface of the SAM crystals was analysed using a scanning electron microscopy (SEM), 
Carry Scope JEOL JCM-5700. Prior to visualisation with the SEM the crystal samples were gold 




 Metastable Zone Width Determination  
Metastable Zone Widths (MSZW) were determined in order to establish suitable levels of initial 
supersaturation to be used in the subsequent crystal growth experiments. The MSZW studies 
involve cooling a saturated solution in an agitated jacketed 500 mL glass reactor with an inner 
diameter of 75 mm, using a 60 mm 4-pitched-blade PTFE coated impeller with inclined blades 
rotating at 400 rpm, under a specific decreasing temperature rate, controlled by a circulator 
(Lauda, RE305 series). A Focused Beam Reflectance (FBRM) probe (Mettler-Toledo) was used 
for in situ detection of nucleation. The MSZW is quantified by taking note of the time when the 
experiment started, the time at which nucleation occurred and the temperature in vessel at this 
time. MSZW determination experiments were performed for SAM at four saturation 
temperatures (15 °C, 20 °C, 25 °C, and 30 °C) using two or three cooling rates (0.5 °C min-1, 
1°C min-1, and 1.5°C min-1) for each of the four solvents (AC, MeCN, EA and MeOH). MSZW 
for PCM have already been determined using similar equipment so was not repeated in this work, 





 Multiple Crystal Growth Method  
 Isothermal Seeded Desupersaturation Growth  
An isothermal seeded desupersaturation (ISD) approach was used to grow multiple crystals of 
SAM at once. Experiments were performed at four crystal growth temperatures (10 °C, 15 °C, 
20 °C, and 25 °C) for each of the four solvents (AC, MeCN, EA and MeOH). A known amount 
of 300-355 μm sieve fraction seeds (< 1 g) were suspended in a slightly supersaturated solution 
(200 mL) in the same reactor as was used for the MSZW studies with inclined blades rotating at 
500 rpm. The initial supersaturation was low to avoid nucleation so worked in the MSZW close 
to solubility line (S < 1.06), solution was heated to 6 °C above the growth temperature. The 
reactor was kept at a constant crystal growth temperature by using a circulator (Lauda, RE305 
series), and the decay in supersaturation was recorded over time. An attenuated total reflectance 
Fourier transform infrared probe, ATR-FTIR (Mettler-Toledo ReactIRTM iC 10), was utilized to 
measure the solution concentration in-situ. The system operates in the mid-IR region, from 1900 
cm-1 to 650 cm-2, with 152 scans every minute. This concentration decay undergoes first 
principles data treatment using the built-in feature within the IR software to smoothen the data 
from the IR spectra. IR data was converted to concentration by assuming that the relation 
between the measured IR responses and the concentration of involved component in the solution 
was linear. A FBRM probe was used to detect the total counts of crystals in situ i.e. this ensured 
that no unwanted nucleation was observed. Examples of both IR and FBRM signals obtained 
during the growth experiments are shown in Figure 3.2. In order to avoid a significant change in 
crystal shape the extent of growth was less than a 30 % linear dimension increase, by adjusting 
the mass of seeds added to the mass being deposited during crystal growth. Assuming nucleation, 
growth rate dispersion, agglomeration and breakage all to be negligible and that the crystal shape 
was constant, the solution concentration decay over time can be related to the size change of the 


























       (17) 
where W0 is the weight of seed crystals and M is the weight of solvent when the unit of 
concentration is g solute / g solvent. L0 is the original crystal size, which is determined by sieving. 
The crystal length L at time t can be obtained by integration of the growth rate, eq. 18: 
  dttcGLL
t




for ,....),,()),(( fTtcG  , where α, β, χ… are parameters of the growth rate equations 
(eqn’s 7, 10, 15 or 16) to be determined by optimization. For the optimization, the lsqcurvefit 
function in MATLAB was used and confidence intervals were calculated using the nlparci 
function. Certain complexities were not taken into account, for example the size and shape 
distribution in the real population of seeds, as this will lead to a much more complex analysis.  
1800 1600 1400 1200 1000 800
 EA



































































Figure 3.2. Example of IR and FBRM signals obtained during the growth of salicylamide in 
ethyl acetate at 15 °C. (a) IR spectra of the solute-solvent solution (SAM – EA) and pure 
solvent (EA), and (b) IR absorbance at 1630 cm-1 and FBRM signal (number of counts) vs 




 Face Indexing of Crystals  
Preferred orientation P-XRD was employed to identifying the crystal faces which were present 
on each of the crystals grown in the different solvents. Same P-XRD settings were used as 
previously described in this chapter. Whole individual SAM crystals grown in each of the four 
solvents were orientated on separate disks with their largest face facing upwards. Furthermore, 
to make identification of the smaller end faces of the crystal possible the long rectangle crystals 
were also cut in half with a blade and positioned on the disk with their end faces facing upwards 
and re-ran. Also, to check if a different polymorph formed during growth in EA, a powder sample 
was made by grinding SAM after growth in EA with a pestle and mortar and again analysed by 
P-XRD.  
BIOVIA Materials Studio Morphology Prediction was used to predict the vacuum growth 
morphology of SAM and PCM FII/ FIII using the attachment energy method, in which the 
growth rate of each crystal face is assumed to be proportional to the attachment energy, viz. the 
energy released upon attachment of a growth slice to a given crystal face. All modelling was ran 
using previously published salicylamide or piracetam crystallographic data (Ref: SALMID01 for 
SAM FI, BISMEV for PCM FII, and BISMEV01 for PCM FIII) [6, 7]. The COMPASS II force-
field was used for both the morphology prediction and the attachment energy calculations. Force-
fields are a mathematical description of classical forces or potential energies between both 
covalent bonded atoms (bonds, angles, torsions) and also non-bonded atoms (van der Waals and 
electrostatics). Additionally, this software was used to model the surface chemistry of the 
dominating crystal faces. Within the Morphology Prediction, interfacial angles can also be 
calculated. Experimental interfacial angles were measured directly from micrographs using built 





 Single Crystal Growth  








Figure 3.3. Apparatus set-up for crystal growth studies using a cuvette placed in a closed tank 
and positioned onto an optical microscope stage.  
A spectrophotometer cuvette 0.4 mL (55 x 10 x 1 mm, Starna Cells 21-SOG-1) was used as a 
growth vessel to study the growth of single salicylamide crystals. Both the growth of seed 
crystals (sieve fraction 300 - 355 μm) and also spontaneous nucleated crystals was studied under 
stagnant growth. At the start, crystal seeds were either mechanically placed inside the cuvette 
before the start of the growth experiments or they were generated by primary nucleation in situ 
in the cuvette. For both crystal types, the cuvette was filled with a supersaturated solution; which 
was prepared by dissolving excess solute in a solvent with sufficient mixing for a minimum of 1 
hour and then let to settle and filtered with a 0.2 µm filter. This cuvette was placed into a shallow 
closed tank of water connected to a circulator (Lauda ECO Silver, RE415) to control the growth 
temperature at 15 °C and placed onto the microscope stage as shown in Figure 3.3. Crystals were 
allowed to grow for 1 hour, with micrographs captured at either 1 or 10 minute intervals using 
the optical microscope. The spontaneously nucleated crystal growth experiments use a relatively 
higher supersaturation, S-1 in the range of 0.24 – 0.89, than compared with the seed crystal 
growth experiments, S-1 in the range of 0.02 – 0.12, to induce spontaneous nucleation. The 
growth of a minimum of 5 crystals were determined for each condition, so that an average of the 
growth rates could be calculated. Crystal growth of both single crystal types were studied in four 
solvents (AC, MeCN, EA or MeOH). Also, each crystal type was studied under two different 
supersaturations within each solvent. The crystal increased in size for the first 2 to 10 minutes 
for spontaneously nucleated crystals and 30 minutes to 60 minutes for seed crystals but then 


















Figure 3.4. Apparatus set-up for single crystal growth studies using a rotating disk. The 
schematic on the left is not to scale: glass disk has diameter 60cm, and hole in center, for 
stirrer, is 10cm.  
A jacketed 500 ml glass reactor with inner diameter of 75 mm and a rotating 60 mm glass disk, 
as shown in Figure 3.4, was used as the growth vessel to study the growth of multiple single 
crystals of salicylamide and also two polymorphs of piracetam. The reactor was kept at a constant 
crystal growth temperature by using a circulator (Lauda, RE305 series). A total of 32 crystals, of 
sieve fraction 300-355 μm and 250-400 μm for SAM and PCM respectively, were attached 
evenly onto the glass disk using a thin layer of epoxy resin, and allowed to set for a minimum of 
three hours at 40 °C. Crystals were orientated in such a way so that they were lying flat on the 
disk with their largest facet facing upwards, they were gently placed on top of the glue so they 
did not become embedded within the resin which allowed both the top and side facets of the 
crystal to grow. A slightly supersaturated solution was prepared in the reactor by adding a known 
amount of excess solute to 200 mls of solvent and let to mix at 250 rpm using a 60 mm 4-pitched-
blade PTFE coated impeller with inclined blades at 6 °C above crystal growth temperature for 
20 minutes. Reactor temperature was then decreased to the required growth temperature, and 






a 316 stainless steel rod which had the glass disk (with crystals) attached using steel nuts and 
washers. The disk was left rotating at 200 rpm for a growth period of 1 hour, and removed from 
solution after and dried for 10 minutes at room temperature. Micrographs of each crystal were 
captured before and after the growth period using an optical light microscope. Growth rates for 
each of the 32 crystals and also the average growth rate of all the crystals grown in one system 
were calculated. The crystal growth of single SAM crystals were studied at 15 °C in four different 
solvents (AC, MeCN, EA or MeOH) and at different supersaturations (S-1 of 0.007 - 0.05). In 
acetonitrile also the influence of temperature was investigated by additional experiments at 10 
and 20 °C. The crystal growth of single PCM FII and FIII crystals were studied at 20 °C in two 
solvents (ETOH and IPrOH). In ethanol the influence of supersaturation (S-1 of 0.05 - 0.30) and 
temperature (25 and 30 °C) on the crystal growth of the two polymorphs was also investigated.  
Certain experimental variables were tested to determine the optimum working parameters for the 
rotating disk experiments which are defined above. To ensure that the decay of supersaturation 
concentration was negligible throughout the growth period the concentration decay was 
measured experimentally and found to be <3 % i.e. maximum supersaturation decay would result 
in an initial supersaturation of 0.030 decreasing to 0.029 after the one hour of growth. The 
rotating disk method was repeated three times for salicylamide using the same conditions and 
proved reproducible results (0.29 ± 0.02 µm/s). Different growth times were trialled and found 
that a minimum of 20 minutes was required but 2 hours led to a decrease in the growth rate 
(Growth rate of width was 0.09 µm/s, 0.28 µm/s, 0.28 µm/s and 0.25 µm/s for 10, 20, 60 and 
120 mins respectively). The use of a higher number of crystals (48) also resulted in a reduced 
growth rate and so was not deemed feasible. The position of the crystal on the disk was found to 
have no impact on the growth rate obtained.  
 Measuring Single Crystal Growth Rate 
For both of the single crystal growth experiments, micrographs of the crystals were captured 
using an inverted optical light microscope (Olympus IX53) integrated with Olympus SC100 
camera. The size of the crystal in a certain dimension at each time point was measured directly 
from these micrographs using the image/ video capture and analysis software (Olympus Stream 
Essentials). Measurements were taken in both the length & width (maximum and minimum feret 
diameter respectively) direction and more precisely the miller indexed (200) face for SAM (as 




micrographs and measurements taken at different stages during the growth period are shown in 
Figure 3.5. In this case, the (200) face was equivalent to the width measurements divided by two. 
It is worth noting from Figure 3.6 that measuring the growth of SAM in the width direction is 
not always representative of the same crystal facet. For the SAM crystal shown on the left, the 
width represents the (200) face, whereas for the SAM crystal on the right hand side the length 
represents the (200) face. This causes issues when reporting growth rates in terms of length and 
width for SAM as it can lead to potentially larger GRD due to measuring growth of different 
faces. Highlighting the importance of reporting growth rates for crystal facets rather than just 
directions.  
 
Figure 3.5. Series of micrographs of salicylamide crystals grown by the cuvette growth 
method using spontaneous nucleation in acetonitrile using S-1 of 0.82 at crystal growth 












Figure 3.6 Micrographs taken during single crystal growth studies, with length and width and 
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 Multiple Crystal Growth of Salicylamide 
This chapter attempts to rationalise the crystal growth process of multiple crystals of 
salicylamide, in particular the kinetics and mechanism by using an isothermal seeded 
desupersaturation growth method [1-5]. These multi-particle crystal growth experiments 
provided overall growth kinetics for the entire crystal population in the crystallisation reactor 
with mixing, which represented industrial process conditions with a controlled hydrodynamic 
environment [6, 7]. The growth kinetics obtained were modelled using several growth rate 
equations, using different representations of the driving force. Furthermore, the crystal growth 
process was examined under a variety of conditions including different solvents, supersaturations 
and temperatures [8-11]. Within the range of experimental conditions, the growth kinetics were 
found to be strongly affected by the temperature and to a lesser degree by the solvent choice. 
Comparison of the growth order parameter revealed a surface integration controlled growth. 
Higher than expected activation energies indicated desolvation as a governing process. A 
comparison of the influence of the solvent on the crystal growth of salicylamide against 
previously published nucleation data at much higher supersaturation showed good agreement, 
but the influence on the interfacial energy was opposite to that observed for crystal nucleation. 
In a detailed comparison with crystal growth data of salicylic acid, there was a consistency in the 
influence of the solvent on the crystal growth of the two compounds. Salicylamide growth 






 Effect of Solvent, Supersaturation and Temperature 
Figure 4.1 shows the recorded supersaturation decay data as a function of time and the 
corresponding curve obtained in the fitting of the simple overall growth rate equation, eq 15, to 
the data. The corresponding crystal growth rate as a function of supersaturation in the four 
solvents at four different temperatures are given in the diagrams to the right. The growth rates 
increases with increasing temperature in all four solvents as expected, but the increase is not 
entirely even. The growth rates increase with supersaturation, and range up to 0.4 ms-1 which 
is in agreement with growth rates previously reported in the literature [5]. The maximum growth 
rate depends on the solvent and the temperature, but this is mostly governed by experimental 
conditions and limitations (e.g. assuming that nucleation does not occur). Parameters of eq 15 
are given in the Table 4.1. The growth order parameter g is in all cases above unity, indicating 
that crystal growth is at least partly controlled by the surface integration as was also found for 
salicylic acid [5]. No clear trend can be found in how the parameters, g and kg change with 
temperature or with solvent, since a significant parameter correlation is likely to exist between 
the g and the kg values for each case [13]. 
The modified overall growth rate equation, eq 16, has also been fitted to the experimental 
desupersaturation data using the two driving force representations given by eq. 2 and eq 3, S-1 
and ΔμT. A similar good fit of the data was obtained for eq 16 as was obtained for eq 15 which 
was shown in Figure 4.1. As shown in Figure 4.2 (S-1) and  (ΔμT) regardless of the driving force 
approximation used, the temperature dependence becomes more even compared to using eq 15. 
This is expected since the temperature dependence is built into the growth rate equation and is 
determined by fitting to all data at all temperatures for each solvent. As is shown in Figure 4.4, 
with respect to the influence of the solvent there is a difference between the two driving force 
representations, originating from the fact that the correction for the activity coefficient ratio is 
solvent and temperature dependent. Notably, using ΔμT leads to a less temperature dependent 
influence of the solvent, i.e. at both temperatures shown in Figure 4.4, the order of growth rates 
at equal driving force essentially is: MeCN > MeOH > AC > EA. When representing the driving 
force in terms of relative supersaturation (S-1), the order between the solvents changes with 
temperature: at 25 °C, the order is the same as when using ΔμT, whereas at 10 °C the order is 




account. ΔμT also takes temperature effects on the driving force into account, which is not the 
case using S-1 as a driving force representation. The results stress the importance of the choice 
of representation of the driving force when growth rates in different solvents and at different 
temperatures are compared, as previously found for salicylic acid [5]. 
Figure 4.5 shows the saturated solution properties of salicylamide in acetone, acetonitrile, ethyl 
acetate and methanol. The mass ratio solubility shown in Figure 4.5a were calculated from the 
mole fraction solubility. In mass ratio terms, the solubility of salicylamide is relatively high in 
acetone and lower in methanol, ethyl acetate and acetonitrile. Solubility regression curves are 
also plotted in the figures over a temperature range from 10 °C to 25 °C, which is used in this 
study. Activity coefficients of salicylamide at saturation in these four solvents were measured 
experimentally from solid-liquid equilibrium data and are plotted in Figure 4.5b. The activity 
coefficient of salicylamide at saturation in acetonitrile (2.13 – 1.95) is greater than in methanol 
(1.62 – 1.61), ethyl acetone (0.87 – 0.79) and acetone (0.51 – 0.44). A value of the activity 
coefficient higher than unity implies that solute-solute interactions are more favourable than 
interactions between solute-solvent (acetonitrile or methanol); in contrast, relatively strong 
interactions between solute-solvent result in values of the activity coefficient below 1 (ethyl 
acetate and acetone). The comparatively strong solute-solute interactions predicted in acetonitrile 
and methanol are substantiated by experimental findings showing these solvents do in fact lead 
to faster growth rates compared with the other systems. With increasing temperature, the solution 
behaviour approaches ideality, and values of the activity coefficient in all solvents tend towards 
unity. The molar ratio of solvent to solute in saturated solution and mole fraction solubility are 
compared at different temperatures in Figure 4.5c,d. Unsurprisingly, the molar ratio of 
acetonitrile to salicylamide is much higher compared with the values in other solvents due to the 
lower solubility of salicylamide in acetonitrile. 
In Table 4.2 the parameters obtained by fitting eq 16 to the experimental data are given. 
Regardless of solvent and driving force representation used, the g value is above unity as was 
also found using eq 15, indicating again that the crystal growth is at least partly controlled by the 
surface integration. The g value changes with the solvent, overall corresponding to the influence 
on the growth rate. The lowest g value is found in methanol where the growth rate is the highest, 
and the highest g value is found in ethyl acetate where the growth rate is the lowest. This relation 
is logical since a lower growth rate can be due to a slower surface integration for which we would 
expect a higher g value, and vice versa. The order between the solvents with respect to the value 




moderately influenced by the driving force choice, with a tendency of being lower when using 
S-1. The rate constant value kg0 when using S-1 has the units of m/s and in all cases receives a 
numerical value of the expected order of magnitude. The corresponding rate constant when using 
ΔμT has units of J/mol and the variation depending on the solvent is several orders of magnitude. 
Again, it can be suspected that much of the variation stems from numerical correlation between 
parameters. 
As shown in Figure 4.3, the growth rate is strongly dependent on the temperature. In methanol, 
at a driving force of ΔμT = 20 Jmol
-1, the growth rate increases by a factor 7 when the temperature 
is increased from 10 °C to 25 °C. The corresponding factor in acetone is 4. This strong 
dependence is of course reflected in the activation energies, Ea, with values given in Table 4.2. 
The activation energy order with respect to the solvent when using ΔμT is: MeCN > MeOH > EA 
≥ AC. When using S-1 the activation energy obtained in EA is lower than in AC. It is worth 
noting that while g does not depend strongly on the driving force representation, the activation 
energy, Ea, does, and the higher value obtained in methanol when using ΔμT, is more in line with 
expectations. These activation energies are clearly higher than the values expected for simple 
molecular diffusion (5 – 20 kJmol-1), and nearer those reported for surface integration (40 – 60 
kJmol-1) [14]. The surface integration step contains different physicochemical processes like 
desolvation, surface diffusion and lattice integration. All data together suggest that the crystal 
growth depending on the solvent and temperature is at least partly governed by the surface 































Figure 4.1. Graphs to the left show supersaturation decay curves (dots are experimental values 
and lines are fits of eq 15), and graphs to the right show the corresponding growth rate curves 
for salicylamide at four temperatures in four solvents. 




















































































































































































































































Table 4.1. Parameters of eq 15 given with 95% confidence limit for desupersaturation 

























kg x 105, m/s g 
MeOH 
25 2.00 ± 0.65 1.05 ± 0.06 
20 2.11 ± 0.69 1.18 ± 0.08 
15 3.94 ± 1.39 1.34 ± 0.07 
10 1.71 ± 0.60 1.30 ± 0.07 
AC 
25 4.15 ± 2.23 1.26 ± 0.10 
20 1.21 ± 0.65 1.13 ± 0.10 
15 0.76 ± 0.40 1.10 ± 0.11 
10 2.43 ± 0.81 1.42 ± 0.08 
MeCN 
25 1.82 ± 1.086 1.05 ± 0.11 
20 2.05 ± 0.58 1.21 ± 0.06 
15 1.96 ± 0.68 1.30 ± 0.08 
10 0.82 ± 0.15 1.29 ± 0.04 
EA 
25 2.29 ± 1.16 1.32 ± 0.11 
20 0.96 ± 0.36 1.20 ± 0.10 
15 3.64 ± 1.54 1.72 ± 0.11 
10 1.18 ± 0.39 1.46 ± 0.09 















Figure 4.2. Growth rate curves of salicylamide at four temperatures in four solvents obtained by 



















Figure 4.3. Growth rate curves of salicylamide at four temperatures in four solvents obtained 
by fitting experimental results to the modified rate eq 16 using driving force representations of 
ΔμT. 
  


























































































































































































































































































































Figure 4.4. Effect of temperature and driving force representation on growth rate of 
salicylamide in four solvents, at two temperatures, obtained by fitting experimental results to 
the modified growth rate eq 16 with the driving force s represented by S-1 and ΔμT, 
respectively. 

































































































































































Figure 4.5. Solubility of salicylamide: scatter plot obtained from experimental data and solid 
line obtained from regression curves (a); activity coefficients in saturated solution (b); molar 
ratio of solvent to solute (c) and mole fraction of solute (d). 








































































































































Table 4.2. Parameters of eq 16, given with 95 % confidence limit for desupersaturation 
experiments in four solvents. 
 
   gg S
RT
E








Solvents kg0 x 105, m/s g Ea, kJ/mol kg0, m/s/(J/mol)  g Ea, kJ/mol 
MeOH 1.12 ± 0.94 1.12 ± 0.03 60.06 ± 2.1 (1.50 ± 1.73) x107 1.15 ± 0.02 88.4 ± 2.9 
AC 12.8 ± 23.3 1.37 ± 0.04 58.70 ± 4.0 15.2 ± 4.77 1.41 ± 0.01 58.5 ± 8.3 
MeCN 4.97 ± 5.65 1.28 ± 0.03 96.40 ± 2.6 (3.15 ± 1.28) x107 1.32 ± 0.02 91.2 ± 1.1 
EA 1.83 ± 2.68 1.40 ± 0.04 55.90 ± 3.3 (2.72 ± 2.56) x104 1.60 ± 0.04 80.7 ± 2.5 
 
  








It should be stressed that the difference between the different driving force representations can 
be significant, and moreover, the difference is highly solvent-dependent. The largest difference 
observed between Δμ calculated by including and neglecting the activity coefficient contribution, 
respectively, is 37 % in acetone, while in methanol the difference is close to zero. This is due to 
the fact that activity coefficients, and their influence on Δμ, depend on the solvent. The difference 
between the two representations not only depends on solvent, however, but also on temperature; 
increasing temperature results in a decrease in the difference between the representations in 
MeOH (from 5 % to -3 %) and EA (from 28 % to 24 %), while it remains virtually constant at 
all temperatures in AC (37 %) and MeCN (22 %). ΔμT accounts for the concentration dependence 
of the activity coefficient, which in many cases is expected to dominate the total influence of 
non-ideality on the driving force. [15] However, it should be noted that some solutions evaluated 
in this work are fairly dilute, and thus that the temperature dependence of the activity coefficient 
is expected to be more important than assumed in the derivation of eq 3. For these cases, we 





 Facet Growth Rate Models: Effect of Solvent and Temperature 
In applying the BCF and the B&S equations 7 and 10 respectively, it should be noted that the 
crystal growth rate data obtained from the isothermal seeded desupersaturation experiments 
represents an average over a number of crystals growing simultaneously, as well as an average 
over the growth of different faces. Accordingly, in the application of face growth models to such 
data the physical parameters determined have to be understood as averages over the different 
faces [5]. Both growth models provide a good fit to the experimental data as shown in Figure 
4.6. The BCF model gives a slightly better fit at 10 °C and 25 °C according to the residual curves. 
Table 4.3 and Table 4.4 list the fitted parameters of the BCF and B&S models, and the surface 
diffusion dependent parameters A and C for each solvent are plotted versus the inverse 
temperature in Figure 4.7. In all cases the graphs show a reasonably linear increase in the 
parameter value with decrease in inverse temperature from which the surface diffusion activation 
energy, Ea,surf, is determined according to eq 13. The surface diffusion activation energies are 
given in Table 4.3 and Table 4.4 and for both models follow the same order with respect to the 





















Figure 4.6. Desupersaturation curves in acetonitrile at two different temperatures (a) showing 












Figure 4.7. Influence of temperature on BCF and B&S parameters in different solvents. 
 
  




































































































































































































































































 Discussion  
 Comparison of Crystal Growth with Nucleation  
According to the results, the crystal growth rate of salicylamide in the four different solvents at 
equal driving force (ΔμT) decreases in the order: MeCN > MeOH > AC > EA. Regardless of 
temperature, the growth rate in EA is clearly lower than in the other solvents and the growth rate 
in MeCN and MeOH is quite similar. When the driving force is described by S-1 the order is 
more dependent on temperature, but at 15 °C the order is MeOH > AC > MeCN > EA. In Figure 
4.8 the latter data are compared with data from a study over primary nucleation of salicylamide 
in the same solvents [16], from which also approximate crystal growth rates are estimated by 
calculating growth rates to be the inverse of growth time parameter (tg) which is taken from eq 
6. These estimates assume that the crystals become visible when they reach a size of 1 m, which 
of course is only an arbitrary value based on the findings of R. Devi, M. Svard et al [17]. 
However, within this assumption, the crystal growth rates from the nucleation experiments are 
in the order of 20 times higher, as would be expected from the much higher supersaturation under 
which the crystals are grown in the nucleation experiments. However, the order of growth rates 
with respect to the solvent exactly matches the order found in the present study. Methanol 
provides the fastest growth for salicylamide crystals, both at the nucleus stage at high 
supersaturation and for the much larger seed crystals at lower supersaturation, whereas ethyl 
acetate leads to the slowest growth rates. This shows that the growth of salicylamide crystals of 
varying size (< 1 μm and 355 μm up to 1000 μm) and under different driving forces were 
influenced in the same way by the different solvents even though the growth mechanism may 
actually be different.  




























 Growth rate from present study
 
Figure 4.8. Growth rates of salicylamide obtained from multi-particle crystal growth studies at 
15 °C with S-1 of 0.01 (this work), compared with the growth rates obtained from nucleation 




The B parameter in the spiral growth model is directly proportional to the interfacial energy (eq 
9), and the D parameter in the birth and spread model is proportional to the interfacial energy 
raised to the power 2 (eq 12). Accordingly, based on the parameter values given in Table 4.4 and 
that the molecular volume, Vm, of salicylamide is equal to 0.171 nm
3 as obtained from the crystal 
density, and assuming the height of the growth step, h, is equal to the cubic root of Vm i.e. 0.56 
nm., the interfacial energy was determined using the B&S model and found to follow the order 
of EA > AC > MeCN > MeOH. According to eqs 9 and 12, a low interfacial energy leads to a 
high crystal growth rate, which is in agreement with the results from the growth rate experiments 
reported in this work. It is widely accepted that the solid-liquid interfacial energy appears as a 
governing parameter also in crystal nucleation. For this reason, values previously reported from 
nucleation experiments are compared with interfacial energies obtained from crystal growth data 
using the B&S model in Figure 4.9. The interfacial energies obtained from nucleation 
experiments follow an order exactly opposite to that of the B&S growth data: MeOH > MeCN > 
AC > EA. In the BCF theory the interfacial energy determines the radius of the growth spiral, 
while in the B&S theory the interfacial energy is based on the "birth" term of the B&S equation 
which can be considered as a 2D nucleation on a substrate surface, which explains why the 
interfacial energy obtained from crystal growth data is expected to be significantly smaller than 
that obtained from nucleation data (3D nucleation). However, at present we have no clear 
explanation why the influence of the solvent on the interfacial energy as determined from crystal 
growth and nucleation experiments, respectively, show completely opposite trends, and this 
disagrees with our previous findings for salicylic acid [16]. One possibility would be that the 
faces governing the crystal growth process do not have the same importance for the formation 
of nuclei. It is well understood that the supersaturation dependence of the growth rate of different 
faces can be different leading to that faces governing the growth at low supersaturation do not 
































Figure 4.9. Interfacial energies obtained from the fitted parameter D of the B+S crystal growth 
model for growth data compared with values obtained using the classical nucleation theory 





 Comparison of Crystal Growth of Salicylamide versus Salicylic Acid 
The same crystal growth method has been used previously to study salicylic acid [5]. Salicylic 
acid (SA) has an identical molecular structure except for the amide group in the meta-position 
being replaced by a carboxylic acid group. Various properties of the two solutes are shown in 
Table 4.5. The molecular weight is essentially the same, while the melting temperature of SA is 
about 20 K higher, and the crystal density of SA is somewhat higher and accordingly the 
molecular volume is a bit lower. The hydrogen bonding capability differs somewhat, 
contributing to differences in the crystal structures. Both salicylic acid and salicylamide 
molecules form dimers, but in addition to this motif the SAM molecules are also involved in 
other intramolecular hydrogen bond interactions. Ultimately, the differences in the hydrogen 
bonding are likely to play a significant role in the variances of growth rates obtained for the two 
solutes. The packing arrangements in the two structures differ considerably as illustrated in 
Figure 4.10. Because of the structural differences, the two compounds crystallize in completely 
different habits, as is further discussed below. 
Table 4.5. Physical and crystal properties of the two solutes, salicylic acid versus salicylamide.  
Property  Salicylic Acid (SA) Salicylamide (SAM) 
IUPAC name 2-Hydroxybenzoic acid 2-Hydroxybenzamide 








Molar mass (g/mol) 138.12 137.14 
Extrapolated Onset Melting 
Point (°C) 
158.2[18] 138.7 [19] 
Density (g/cm3) 1.44 1.33 







Salicylic Acid (SA) Salicylamide (SAM) 
 
 
Figure 4.10. Unit cell representations showing hydrogen bonds (blue lines) the two solutes, 
salicylic acid versus salicylamide were obtained using the software Materials Studio for 
structures with CSD refcodes: SALIAC16 and SALMID01. 































































Figure 4.11. Crystal growth rate curves at (a) 10 °C and (b) 25 °C for salicylamide (present 
work; dashed lines) and salicylic acid [5] (solid lines) in four solvents at different driving 
forces obtained by fitting experimental results to the modified growth rate eq 16 with the 
driving force, s, represented by ΔμT.  
 
In Figure 4.11, crystal growth rates of salicylamide are compared with salicylic acid in the same 
solvents at two temperatures. In both cases the driving force has been estimated according to eq 
3 using the same approximation of the activity coefficient ratio [15]. At lower temperatures, the 
growth rates of the two compounds follow a similar solvent order, whereas at higher 
temperatures they follow a different order. For salicylamide, the growth rate at all temperatures 
decreases in the order: MeCN > MeOH > AC > EA, while for salicylic acid the solvent order 
changes with temperature: at 10 °C the order is MeCN > MeOH ≥ EA ≥ AC, while at 25 °C the 




kinetics for both solutes at 10 °C. Ethyl acetate provides the slowest growth rates for 
salicylamide, whereas acetone provides the slowest growth rates for salicylic acid consistently 
at both temperatures. Accordingly the order with respect to the solvent does not match perfectly 
for the two solutes. However it should be acknowledged that there is some uncertainty in the 
curves as shown in fitting; this could have a considerable effect on the solvent order in the case 
of salicylic acid for which the curves are close together. Salicylic acid exhibits a clearly faster 
growth than salicylamide in all solvents at the lower temperature (10 °C), whereas salicylamide 
has the faster growth in all solvents except EA at the higher temperature (25 °C) as illustrated in 
Figure 4.11. As regards the temperature dependence on the crystal growth rate, for salicylic acid 
in acetonitrile at ΔμT of 10 Jmol
-1, the growth rate increases from 1.4 × 10-8 ms-1 up to 2.5 × 10-
8 ms-1 with a 15 °C increase, which equates to a factor of 2. Under similar conditions, for 
salicylamide the growth rate increases from 1.1 × 10-8 ms-1 up to 7.0 × 10-8 ms-1, i.e. by a factor 
of 6. This shows that under the evaluated conditions the impact of increasing temperature has a 
significantly greater impact on the growth rate of salicylamide than salicylic acid. Comparing 
the activation energies obtained by fitting eq 16 using ΔμT it is notable that Ea values are 
significantly higher (from a factor 1.5 up to 4) for SAM in all the solvents. The Ea value for 
salicylic acid is in the range 22 – 67 kJmol-1 while for salicylamide the range is 58 – 91 kJmol-1.  
There appears to be no clear relationship between SAM and SA as regards the parameters kg0 
and g with respect to the solvent. Significantly higher kg0 values were obtained for salicylamide 
than salicylic acid. The values of the growth order parameter g are for all solvent-solute 
combinations above unity with slightly higher values observed for salicylic acid in all solvents 
except ethyl acetate [5]. In comparing the activation energies for surface diffusion it may be 
noted that for SAM the value in MeOH is about 50 % higher compared to SA, while the values 
in AC are roughly the same, the value in MeCN is very much higher (by a factor 5 – 10), and the 





 Conclusion  
Out of four solvents, the crystal growth rate of salicylamide was found to be slowest in ethyl 
acetate under all conditions evaluated. For the remaining solvents, the order with respect to the 
growth rate of salicylamide depends on temperature, supersaturation and driving force 
representation. The growth kinetics are strongly affected by the temperature as reflected in the 
activation energy. The growth order parameter reveals that the crystal growth is at least partly 
controlled by surface integration, with the highest value being found in ethyl acetate where the 
growth rate is the lowest. Higher than expected activation energies and significant influence of 
the solvent indicate that desolvation is a governing process. The influence of the solvent on the 
growth rate of salicylamide is in good agreement with the corresponding growth rates obtained 
in primary nucleation experiments. The BCF model and the B&S model are both well fitted to 
the growth data, and the interfacial energies are estimated. As opposed to similar work on 
salicylic acid, interfacial energies from primary nucleation data have an opposite dependence on 
the solvent to that found for the present growth rate data. Compared with a similar study over 
the crystal growth rate of salicylic acid the influence of the solvent is essentially the same, with 
acetonitrile providing the fastest growth rate for both compounds. Salicylamide crystal growth 
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Face Indexing & Shape Analysis of Salicylamide 






 Face Indexing & Shape Analysis of Salicylamide Crystal Grown In Different 
Solvents 
The focus of this chapter was two-fold; to investigate how salicylamide crystals grew in different 
solvents at a molecular level including the solvent-solute interactions and also to face index 
experimentally grown crystals with different habits for the purpose of observing the correct faces 
during the growth process. SAM crystals grown experimentally in acetone, acetonitrile and 
methanol matched the attachment energy predicted rectangle plate vacuum habit. However, in 
ethyl acetate irregular hexagonal plate crystals form. Single crystal and powder x-ray diffraction 
was carried out to rule out the possibility of a new polymorph. Given no new polymorphs were 
discovered, instead this change in habit was found to be caused by the stunted growth of specific 
crystal faces during the crystallisation process. This alternative habit makes face indexing of 
experimentally grown crystals difficult. Precise face indexing is essential in order to measure the 
kinetics of crystal growth in a characteristic dimension accurately i.e. the correct faces [1, 2]. A 
combination of experimental and modelling prediction tools was employed for the face indexing 
process. The angle between faces combined with preferred orientation P-XRD was found to be 
the most accurate and reliable method leading to successful identification of each salicylamide 
crystal face. The surface chemistry of each face was examined on a molecular level with insights 
into the possible growth attachment sites being made. It was deduced that ethyl acetate could 







 Salicylamide Crystal Habit Grown in Different Solvents 
Salicylamide crystals were grown in each of the four solvents by slow solvent evaporation; 
typically one crystal habit dominated each solvent system. This is illustrated by representative 
crystals for each of the solvents in the micrographs in Figure 5.1. Acetone, acetonitrile and 
methanol mainly formed crystals with a rectangle habit. In ethyl acetate, the salicylamide crystals 
typically formed irregular hexagonal plates. In a few cases crystal habit did also change within 
each solvent system, for example ethyl acetate had the capabilities of forming crystals with a 















Figure 5.1. Micrographs of crystals grown by slow solvent evaporation in the different 









 Salicylamide Crystal Morphology Prediction  
According to the computational prediction by the attachment energy approach shown in Figure 
5.2, the salicylamide crystal grown in vacuum forms a rectangular shaped particle containing 16 
facets, with only 5 being unique. The modelling predicts flat sides (facets (200), (002) and (011)) 
and slanted top and bottom made by facets (11-2) and (110). Overall, the most dominant, thus 
the slowest growing are equivalent (002) and (00-2) faces which jointly take up 51.4% of the 
total surface area (see Table 5.2). Crystals grown in acetone, acetonitrile and methanol (Figure 
5.1 a, b, d) gave similar habit to the predicted. However crystals grown in ethyl acetate (Figure 















Figure 5.2. The growth morphology (computational attachment energy prediction, 





 Check for Polymorph 
Although an altered crystal habit is not a sole indicator of polymorphism, it can be used as an 
initial test. To ensure the crystals with irregular hexagonal habit grown in our study were not a 
new polymorph, both P-XRD and SC-XRD data was collected. A powder sample of SAM was 
made by grinding SAM as supplied with a pestle and mortar and placing on sample holder. This 
powder sample was analysed by P-XRD and results were compared with a previously published 
P-XRD pattern of salicylamide [3]. Both patterns match as shown in Figure 5.3 indicating that 
SAM in this study forms the same polymorph as the previously reported stable Form I. In order 
to confirm for definite there are no minor changes in the crystallographic data we also determined 
the unit cell of SAM crystal grown in EA with irregular habit through SC-XRD and compared 
against previously reported crystallography data [3]. This confirmed for certain the same stable 
polymorph, Form I, was formed with the monoclinic I 2/a cell setting.  
 
Figure 5.3. Powder XRD pattern of salicylamide sample as used in this work (2nd pattern is 
calculated from SC-XRD data obtained as part of this work and reported in [4], 3rd pattern is 
ground salicylamide sample as received) compared to previously published salicylamide XRD 
pattern [3].  
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 Face Indexing 
Step 1: Overlay of predicted habit onto experimental habit 
As it is has been shown that all crystals grown in the different solvents are of the same 
polymorph, it indicates the change in crystal habit is due to different growth rates of the same 
faces in the different solvents. The irregular habit makes face indexing difficult. Experimentally 
grown crystals which had a similar habit to the predicted can easily be subjectively indexed by 
simply overlaying the predicted habit to these micrographs and assigning the corresponding face 
index. The large flat face and the side face as shown in Figure 5.1 a, b, d are likely to be the (002) 
and (200) respectively as predicted by the growth model in Figure 5.2. These can be confirmed 
experimentally by preferred orientation P-XRD in the next section. The end faces are more 
difficult to identify as the three end faces predicted do not always remain in the experimental 
crystals. In some crystals there are only one or two end faces. A more detailed analysis is required 
to identify these end faces correctly as will be discussed at a later stage in this chapter. As for 
crystals with the irregular habit, such as the ones grown in ethyl acetate as shown in Figure 5.1c, 
face indexing is not straight forward and so these crystals also require a more extensive approach. 
Step 2: Preferred orientation P-XRD 
In order to identify the faces of real crystals, separate P-XRD patterns were obtained for whole 
crystals grown in each of the four solvents which were rotated in a preferred orientation onto the 
disk as shown in Figure 5.4. All samples formed the same three peaks, comparing these peaks 
with the previously published salicylamide XRD indexed pattern [3] they infer the (002), (004) 
and (008) faces as shown in Figure 5.5. All are a part of the same (00l) indices family, 
representing different crystal planes. Hence all peaks observed from the preferred orientation 
XRD pattern confirm the presence of the large (002) face as predicted by the growth morphology 
in Figure 5.2. Interestingly, the two crystals grown in ethyl acetate which gave significantly 
different habits both gave the same XRD pattern. Accordingly, both crystals are dominated by a 











Figure 5.4. Micrographs of each of the crystals to be examined by P-XRD, grown in each of 
the four solvents with two crystals for ethyl acetate due to different habit. 
 
Figure 5.5. Previously published salicylamide XRD pattern [3] compared against preferred 
orientation XRD patterns of whole salicylamide crystals grown in acetone, acetonitrile, ethyl 
acetate (1), ethyl acetate (2) and methanol. Miller indices assigned to peaks of interest. 
Additionally, one P-XRD pattern was obtained for multiple whole salicylamide crystals grown 
in methanol which were placed in a preferred orientation onto the disk as shown in Figure 5.6. 
The same three XRD peaks are observed again as were shown for the individual crystal scans. 
Predominantly (00l) face is observed in Figure 5.7 as expected from the modelled habit, again 
confirming the presence of predicted (002) face when compared against previously published 
salicylamide XRD pattern. However, this scan of multiple crystals at once gives an additional 
two peaks indicative of the (200) and (015) faces. The (200) face matches the predicted side face 
of the crystal in Figure 5.2. The (015) is part of the (0kl) family, which matches to the (011) end 
face of the predicted crystal habit. Scanning multiple crystals at once allowed for faces which 
had a small surface area ratio to be amplified and meant that their respective peak intensity could 
be increased and reach the minimum threshold and so not be overshadowed by the larger more 
intense peaks. These new peaks complement the predicted faces in the material studio model.    
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Figure 5.6. Image shows multiple whole salicylamide crystals grown in methanol – all crystals 
were oriented as shown on the disk and analysed by XRD. 
 
Figure 5.7. Preferred orientation XRD patterns of multiple whole salicylamide crystals grown 
in methanol compared against published salicylamide pattern [3]. 
Although running multiple crystals in the preferred orientation led to the confirmation of the side 
(200) face and the end face (011), the large surface area of the (002) face still tend to outweigh 
the other peaks. In order to reduce the intensity of these (00l) peaks, and allow for other peaks 
to be observed, the crystal was cut using a blade and orientated differently so that the faces on 
the end of the crystal were facing upwards as demonstrated with the growth habit in Figure 5.8. 
P-XRD patterns were obtained for two cut individual crystals grown in different solvents to 
account for differences in habits observed from the experimental crystals. The two crystals tested 
gave different peaks as shown in Figure 5.9 which indicates different dominate end faces on the 
samples. Only one peak formed for each of the samples, indicating that one face dominates the 
end of the crystals in both cases. Crystal 1 one which was grown in acetone had a peak 
representing the (110) face confirming one predicted end face. Whereas Crystal 2 which was 
grown in acetonitrile has a peak signifying the (024), this represents the (0kl) indices family 
which confirms the (011) end face as predicted in the growth morphology habit in Figure 5.2. 
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This further confirms that the dominate end faces change between salicylamide crystals, and that 
predicted habit alone cannot just be utilised for accurate face indexing of real crystals.  
 
Figure 5.8. Growth morphology (computational prediction, COMPASS-II force-field) of 
salicylamide crystal; oriented same way as real crystal samples on P-XRD disk so that end 
faces are facing upwards. Miller indices are given for major faces. 
 
Figure 5.9. Preferred orientation XRD patterns of cut & oriented salicylamide crystals grown 
in different solvents compared against published salicylamide pattern [3]. 
The use of preferred orientation P-XRD was instrumental in the face indexing process. This 
technique combined with predicted habit allowed for confirmation of specific faces from real 
salicylamide crystals, ultimately resulting in accurate face indexing of the crystal faces with 
relatively large surface area ratios. P-XRD confirmed the presence of the large flat (002) face, 
the main side (200) face and also some end faces (011) and (110). Experimental confirmation of 
four of the five unique facets predicted was achieved except for the small (11-2) end face. 
However, due to the fact that smaller peaks can be masked by the more dominating peaks it is 
not a suitable technique for identifying the smaller crystal faces. Instead experimentally 
measured interfacial angles will be compared against predicted angles in order to assign accurate 
indices to all the end faces of the crystal. 
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Step 3: Interfacial Angle 
Interfacial angles can easily be calculated from previously published unit cell data using Material 
Studio Morphology software. Calculated angles are shown in Table 5.1. Although a crystal does 
not always maintain geometric similarity during growth (change in crystal habit), the interfacial 
angles do not vary as they are characteristic of the substance which makes them a reliable tool 
for face indexing crystals that have a variable habit [5, 6].  
Table 5.1. Interfacial angles calculated using Material Studio for SALMID crystal habit. 
(h k l) (h k l) 
Interfacial Angle 
(°) 
(  0  0  2 ) (  2  0  0) 79.43 
(  2  0  0 ) (  0  1  1 ) 87.38 
(  2  0  0 ) (  1  1  0 ) 67.01 
(  1  1  0 ) ( 0  1  1 ) 24.57 
(  1  1  0 ) ( -1  1  0 ) 45.98 
(  2  0  0 ) (  1  1 -2 ) 73.59 
( -1  1  2 ) (  0  1  1 ) 22.75 
(  1  1  0 ) ( -1  1  2 ) 47.32 
( -1  1  2 ) (  1  1 -2 ) 62.21 
Typically a goniometer would have been used to measure the interfacial angles directly from real 
crystal samples. Nowadays, interfacial angles can be measured directly from micrographs using 
three point angle measuring tool on Olympus Stream Essentials software. It should be noted for 
the angle to be accurate the crystal needs to be laid flat. Experimentally measured angles shown 
in micrographs below (Figure 5.10) compared well with calculated angles as listed in Table 5.1. 
Figure 5.10a represents crystals with the regular rectangle habit; as acetone, acetonitrile and 
methanol all formed crystals of similar shape only one grown in acetone was reported. In order 
to successfully determine the miller indices of the end faces of the crystal, specific interfacial 
angles were measured; for example the 45.45° angle was calculated to be between the (110) and 
(-110) planes, and 69.74° angle was calculated to be between the (200) and (110) planes. Figure 




interfacial angles of 47.17° was calculated to be between the (110) and (-112) planes, and 66.91° 
was calculated to be between the (200) and (110) planes. Using this information, in both cases 
the Miller indicies can be assigned successfully to the end and side faces of the crystals.  
  
Figure 5.10. Micrographs of individual salicylamide crystals grown experimentally in a) 
acetone and b) ethyl acetate with measured interfacial angles in red text/ lines and assigned 
indices overlaid in black text.  
Step 4: Assigning miller indices to real crystals  
Combining all of the experimental and modelling results from the previous steps, salicylamide 
crystals of both regular rectangle habit and also irregular hexagonal habit were successfully fully 







Figure 5.11. SEM images show individual salicylamide crystals grown experimentally in a) 
























 Molecular Analysis of Particle Interactions  
Uninfluenced by the surroundings, the crystal shape is determined by the crystal structure and 
the solid state molecular interactions.  In its crystal structure, each salicylamide molecule creates 
H-bonding with three neighbouring salicylamide molecules through the hydroxyl (-OH), amine 
(-NH2) and carbonyl (-C=O) polar groups as shown in Figure 5.12. A centrosymmetric dimer 
present in the crystal lattice is stabilised by H-bonding with adjacent molecules. In molecular 
crystals, strong intermolecular interactions (such as H-bonding) tend to determine the growth 
directions [3, 7-9]. Thus, it can be expected that the growth rate may be higher in hydrogen 
bonding directions leading to the corresponding faces becomes small.  
 
Figure 5.12.An arrangement of H-bonds (black dots) in the crystal structure of salicylamide 
projected along the crystallographic c-axis. Highlighted is the salicylamide dimer. Hydrogen – 
white, carbon – grey, oxygen – red, nitrogen – blue. 
The crystal shape predicted by the attachment energy method is shown in Figure 5.2 and Figure 
5.8. The crystal is dominated by the (002) faces and bound by (200) side faces. The attachment 
energy of the five slowest growing faces are given in Table 5.2. The attachment energy of the 
(002) face is -170.4 kJ/mol, being only half of the value for the second slowest growing side face 
(200), having the attachment energy of -357.0 kJ/mol. The difference to the following three faces 




Table 5.2. Calculated attachment energy and total area for stable configurations of major facets 
predicted with the growth morphology method using the COMPASS II force-field. 
Facet (h k l) Eatt (kJ/mol) Area (%) 
(0 0 2) -170.4 51.4 
(2 0 0) -357.0 24.2 
(0 1 1) -415.7 18.0 
(1 1 −2) -466.2 3.3 
(1 1 0) -487.2 3.1 
 
 Figure 5.13 Molecular representations of crystal faces of salicylamide. Both 3D and 2D 




In Figure 5.13, the molecular chemistry of the five slowest growing faces is shown. The slowest 
growing (002) faces feature protruding non-polar phenyl rings, were the contribution of van der 
Waals and -interactions are likely to dominate (Figure 5.13e). The contribution from hydrogen 
bonding is low and thus the face is non-capable of making strong hydrogen bonding interactions 
with the solvents. Accordingly, the growth rates of these faces are not expected to be strongly 
influenced by the solvent. The (200) faces appears to be more polar, however the propensity for 
hydrogen bonding is reduced by the fact that it is the internally rotated hydrogen bonded alcohol 
group that dominates the surface and the amide groups are embedded deeper into the surface 
topology. The short side faces of the simulated crystal shape all have a more clear propensity for 
hydrogen bonding, which also explains why these are the smallest faces in Table 5.2, especially 
(110) and the (11-2).  
The crystal grown in acetone (Figure 5.11) is not very different from that predicted by the 
attachment energy method. The crystal is clearly dominated by the (002) faces and the elongated 
(200) face is quite similar to that found in the predicted shape (Figure 5.2). Also, the (011) face 
is clearly seen on the short side of the crystal. In ethyl acetate, the salicylamide crystals form 
irregular hexagonal plates looking quite different from those in acetone. However, at closer 
inspection it is found that it is in fact the short side faces that has been slowed down by which 
the (200) faces become less dominating. The (110) and (11-2) faces have developed more than 
in the other solvents. However, it should be noted though that the attachment energies of these 
faces are not much higher than that of the (011) faces, indicating that just a modest slowing down 
of the growth rates for the (110) and (11-2) faces will result in the shape change as seen in ethyl 
acetate. As shown in Figure 5.13a and b, the (110) and (11-2) faces feature exposed amine groups 
(-NH2), especially capable of hydrogen bond donation. However, we suspect that the change in 
shape, as observed in ethyl acetate, is not due to hydrogen bonding as both acetonitrile and 
acetone are also polar aprotic hydrogen bond accepting solvents. Thus we suspect that the size 
of the ethyl acetate molecule leading to higher propensity for van der Waals bonding, is an 
important factor in explaining that shape is more influenced in ethyl acetate.  
Furthermore, the adsorption energy of the four solvent molecules on the salicylamide (110) 
surface was obtained by Monte Carlo simulations within Material Studio, as shown in Figure 
5.14 [4]. In agreement with the discussion above, it was found that EA is adsorbed strongest on 
the (110) face with an adsorption energy of -48.78 kJ/mol, and the adsorption energy decreases 
in the order EA > AC > MeCN > MeOH. The adsorption of solvent molecules onto the crystal 




EA molecules adsorb embedded in the salicylamide molecule landscape by van der Waals 
bonding. MeCN also absorbs onto the (110) surface by van der Waals interactions alone however 
the adsorption energy is 7.94 kJ/mol (approx. 16%) lower than for EA. EA’s molecular weight 
is over two times the weight of MeCN (88 g/mol versus 41.05 g/mol respectively) and EA 
accordingly covers a far larger surface area of the (110) face. On the other hand, AC adsorbs 
onto the (110) crystal face via van der Waals interaction and hydrogen bonding, and MeOH 
adsorption is dominated by hydrogen bonding. Hydrogen bonding is directional and leads to the 
molecule “sitting on top of” the surface rather than becoming embedded in the topology.  
 
 
Figure 5.14. Adsorption of solvent molecules onto the (110) face of salicylamide growth 
morphology performed using the adsorption locator calculator on material studios. Solvents 
adsorbed in the respective images are EA (ethyl acetate) on top and MeOH (methanol) on the 
bottom. Note the images shown here are an enlarged representative area taken from the full 




 Conclusion  
Salicylamide crystals grown experimentally were successfully face indexed using a combination 
of experimental and modelling techniques. Preferred orientation P-XRD combined with 
overlaying predicted habit allowed for experimental confirmation of the (002), (200), (011) and 
(110) faces from real salicylamide crystals. Due to the changing nature of salicylamide’s crystal 
habit grown under the same conditions in different solvents, comparing calculated interfacial 
angles against experimental angles was found to be the most reliable and consistent method for 
face indexing. The salicylamide crystal habit is most greatly affected by EA as compared to the 
habit of its crystals grown in AC, MeCN and MeOH. The underlying reduction of the growth of 
the salicylamide (110) face is likely due to stronger van der Waals interaction of EA molecules 
with the crystal surface. The adsorption energy of MeCN on the (110) face is lower because the 
molecule is smaller, as is the adsorption energy of AC and MeOH in spite of their greater 
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 Single Crystal Growth of Salicylamide 
This chapter examines the crystal growth of single salicylamide crystals directly using a 
microscope to improve our fundamental understanding of the crystal growth process. This 
chapter details the use of two different growth methods including a traditional single crystal 
growth method which uses a non-stirred cuvette and also puts forward an alternative multiple 
single crystal growth method which uses a rotating disk in an attempt to overcome some of the 
issues we face in the former and ultimately make a more robust method for examining the single 
crystal growth. Such issues have already been discussed in section 2.2.3.3; including its time 
consuming nature given the fact that each crystal can grow at different rates, also within each 
crystal each facet can have different growth rates and furthermore the experimental issues that 
arise when attempting to track the growth of a single crystal in a moving solution. In the growth 
cuvette the crystal growth rates were measured for both primary nucleated crystals and seed 
crystals manually inserted into the cuvette. Such measurements are helpful in that they provide 
baseline crystal growth kinetic data from which the impact of e.g. seeds and agitation can be 
assessed subsequently. In the rotating disk experiments seed crystals were attached to a disk that 
was rotated in a supersaturated solution. The crystal growth rates in the length and width 
direction were precisely measured in-situ for each individual crystal; and growth rates were also 
extracted for a specific crystal facet i.e. (200). The impact of organic solvent, supersaturation, 
temperature, and hydrodynamic conditions on the crystal growth was studied. In all cases, the 
growth rate is considerably faster in the rotating disk experiments. Within the range of 
experimental conditions, the growth kinetics were strongly affected by the temperature and to a 
lesser degree by solvent choice. The influence of the supersaturation depended on the solvent. 
The crystal seed quality was found to have a substantial impact on the growth rate, with rougher 






 Cuvette Growth Method 
 Habit 
Individual spontaneously nucleated crystals and seed crystals grown in a stagnant solution in 
each of the four solvents under different supersaturations are shown in Figure 6.1. Under certain 
conditions, spontaneously nucleated crystals and seed crystals can grow to a maximum width of 
500 µm and 850 µm respectively. Seed crystals grew 2.5 times the size in the width direction 
and 5 times the size in the length direction at certain conditions (850 x 1700 µm). For crystals 
that were spontaneously nucleated as shown in the top two rows, the crystal habit differed 
depending on the solvent and initial supersaturation. When crystals were formed and grown from 
acetone and methanol, the rectangle crystal habit of salicylamide depended on the level of initial 
supersaturation, were at the lower supersaturation less elongated particles were being observed. 
On the other hand, in acetonitrile, regardless of the initial supersaturation, elongated rectangle 
particles were formed. In ethyl acetate, the crystals formed irregular hexagonal plates regardless 
of the initial supersaturation. This habit change and has been discussed in detail in the previous 
chapter 5. When performing similar single crystal growth studies but using seed crystals as 
shown in the bottom two rows, the influence of solvent on the crystal habit of salicylamide 
appears to be negligible. Instead, the initial rectangular plate habit of the seed crystal was 
















Figure 6.1 Micrographs of salicylamide crystals grown using the cuvette growth method at 
15°C. The top two rows refer to spontaneously nucleated crystals whereas the bottom two rows 
refer to the seed crystals. For both crystal types, micrographs are shown for each of the four 
solvents, under different supersaturations (σ = S-1 which is 0.89 - 0.06). The crystals displayed 
here represent the dominant habit obtained in each condition, when each condition was 
repeated for a minimum of five crystals. 
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 Effect of Solvent and Supersaturation  
The average crystal growth rate of spontaneously nucleated and seed salicylamide crystals, as a 
function of solvent and supersaturation, is similar for length and width as shown in Figure 6.2. 
Growth rate of the length direction is faster than the growth rate of width direction of crystals at 
all conditions, by a minimum factor of 2. The average growth rate ratio of length to width 
increased with increasing supersaturation value for spontaneously nucleated crystals, whereas 
the ratio decreased with increasing supersaturation for seed crystals as shown in Figure 6.2 (e, 
f). In other words, spontaneously nucleated crystals grow at a similar rate in either dimension 
under the two supersaturations tested. Whereas seed crystals grow differently in the length and 
width dimensions depending on the supersaturation used; crystals grow proportionally faster in 
the width dimension than in the length at the higher driving force. The growth process of 
salicylamide is most strongly effected by change in driving force when EA was used as the 
solvent. The growth rate is found to vary not only from one condition to another, but also among 
the crystals grown in the same condition, this phenomenon being referred to as growth rate 
dispersion (GRD) [14]. GRD is observed at all conditions, the clearest example in EA at 
supersaturation 0.48: from 0.1 μm/s up to 4.3 μm/s among the 5 crystals, see Figure 6.2 (a). The 
growth rate distribution appears to increase with supersaturation in most of the solvents, and also 
within the studies that use spontaneously nucleated crystals. In spite of the fairly strong GRD the 
influence of the supersaturation on the average growth rate in all cases meets the expectation, 
i.e. the growth rate increases with increasing supersaturation. However, the GRD is so significant 
that the evaluation of the influence of the solvent should only be taken as indicative. The growth 
rates of salicylamide crystals growing in the cuvette are considerably influenced by the initial 
supersaturation and the solvent choice as illustrated in Figure 6.2. In the experiments with 
spontaneously nucleated crystals, the driving forces are higher and different for the different 
solvents since nucleation is to be induced. The approximate crystal growth difficulty order is as 
follows MeOH>AC>EA>MeCN. In previous work, the nucleation difficulty order for 
salicylamide was found to be MeOH>AC>MeCN>EA [1]. The solvent appears to be effecting 
the nucleation and crystal growth of spontaneously nucleated crystals in a similar order.  
In the seeded experiments, the same initial supersaturation (S-1) of 0.12 and 0.06 was used 
regardless of the solvent. The order of average crystal growth rate, with respect to solvent, 




growth rate is the highest in acetone and the lowest in acetonitrile, with methanol and ethyl 
acetate in between, in both length and width direction. At the lower supersaturation (0.06) the 
growth rate is still the highest in acetone in both directions, but the order among the other three 
is less systematic as shown in Figure 6.2 (c) and (d). As the cuvette growth method uses a non-
stirred solution the growth rate is likely to be effected by the rate of diffusion through the fluid 
surrounding each crystal, which in turn is inversely proportional to the viscosity of the solution. 
Methanol has the highest viscosity (0.54mPa.s at 25°C), compared to acetone which has the 
lowest viscosity of the four solvents (0.31mPa.s at 25°C) [2]. Using the Wilke and Chang method 
for estimating the diffusivity ranks the solvents in the order AC> EA> MeCN> MeOH. Growth 
order of seed crystals follows similar order as solubility (mol/L) AC>EA>MeOH>MeCN. This 
states that acetone has the highest amount of solute in the total solution compared with other 
solvent-solute solutions with acetonitrile having the lowest which follows the same order as the 

































































































































    
























































































   















































Figure 6.2. Average crystal growth rate (μm/s) of spontaneously nucleated (left) and seed 
(right) crystals in the length (a, b), width (c, d) direction and also average crystal growth rate 
ratio (e, f) as a function of solvent and supersaturation. Crystals are grown using the cuvette 
growth method at a growth temperature of 15 °C. AC is acetone, MeOH is methanol, EA is 
ethyl acetate and MeCN is acetonitrile; number above line is the supersaturation (S-1). The 
center point is the average crystal growth rate while the error bars on the graph illustrate the 
standard deviation of the data. 
  




In the previous chapter we have face indexed experimentally grown salicylamide crystals using 
experimental and prediction techniques [3]. All salicylamide crystals grown in these studies were 
flat plate-like crystals, indicating growth is stunted in one facet direction, this is the (002) face. 
The growth rate of this face is not measured in this study since this face is viewed from an aerial 
perspective. A mix of three end faces (-112), (011), and (110) represent the length direction, 
however all three faces may not appear in all crystals and so are difficult to track between 
crystals. The width typically represents the growth of the (200) and (-200) face; and as the (200) 
face is consistent between crystals, Figure 6.3 shows the influence of the solvent on the growth 
rate of this specific face. Growth rate of the (200) face is found to follow the order of AC≥
MeOH>MeCN>EA at S-1 of 0.06. Growth of the (200) face is slower in ethyl acetate than in the 
other 3 solvents. As previously stated, in the length direction the growth rate in ethyl acetate is 
faster than in acetonitrile. These findings indicate that ethyl acetate provides the slowest growth 
of the (200) facet out of the four solvents tested yet only the second slowest growth rates of the 
faces in the length direction of the crystal. In other words not all faces of the salicylamide crystal 
habit grew at equivalent rates in the same solvent. This in agreement with findings in the 
literature that state solvents may accelerate, retard or even stop the further outgrowth of 
individual crystal faces, sometimes producing a habit change [4].  
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Figure 6.3. Average crystal growth rate of (200) face (µm/s) of seed crystals with respect to 
four different solvents. Crystals are grown using the cuvette growth method at a growth 
temperature of 15 °C and supersaturation (S-1) of 0.06. The center point is the average crystal 





 Rotating Disk Method 
 Habit 
Micrographs taken before and after the growth of salicylamide crystals in the rotating disk 
experiments are shown in Figure 6.4. The final habit appeared to be controlled by the shape of 
the seed as was also found for similar seed crystals grown via the cuvette crystal growth 
experiments. The outline of the seed is visible after growth in the final crystal only because the 














Figure 6.4. Micrographs of salicylamide crystals before and after crystal growth via the 
rotating disk method. Salicylamide seed crystals are grown in each of the 4 solvents at growth 
temperature of 15°C under supersaturation (S-1) of 0.03 for 1 hour. Only one representative 






 Effect of Solvent 
There is little difference between the average growth rates of the seed crystals in the different 
solvents except for EA when using a crystal growth temperature of 15 °C and supersaturation 
(S-1) of 0.03 as illustrated in Figure 6.5. In both the length and width directions ethyl acetate 
provides the slowest growth rates of salicylamide compared to the other solvents.  
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Figure 6.5. Average crystal growth rate of (a) length and (b) width (µm/s) of salicylamide seed 
crystals grown using the rotating disk method in four solvents (AC, MeCN, EA, MeOH) in 
temperature of 15 °C at supersaturation (S-1) of 0.03. Error bars are used to illustrate the 
standard deviation of the data.  
The (200) facet of salicylamide seed crystal grows faster in methanol compared to the other 
solvents, with acetonitrile  and acetone having similar growth rates and lastly ethyl acetate with 
the slowest growth rates as shown in Figure 6.6. As methanol provided the fastest growth rates 
and ethyl acetate the slowest growth rates of the (200) facet, crystals grown in these two solvents 
are examined and SEM images are shown in Figure 6.7. The (200) surface of salicylamide 
crystals is more regular and structured when grown in MeOH than in EA. When examined in 
more detail the topographical features of the surface are different in the two solvents; when 
grown in MeOH the surface appears to have rows of steps whereas when grown in EA the surface 
is slightly different with a corrugated step appearance. It is known that the solvent may change 
the growth mechanism by way of the surface roughness [33, 34]. The rows of steps may allow 
for easy lattice integration in comparison with the corrugated step surface and thus explain the 









































AC MeOH EA MeCN
 
Figure 6.6. Average crystal growth rate of (200) face (µm/s) under rotating disk conditions 
with respect to four different solvents tested (200 rpm, 15 °C, 1 hour, S-1 of 0.03). Error bars 












































Figure 6.7. SEM images of salicylamide crystals after growth via the rotating disk method at 
15°C for 1 hour under S-1 of 0.03 in both EA and MeOH. The bottom two SEM images show 
the topographical features of the (200) facet after growth in both solvents.  
 
(200) 
Methanol  Ethyl Acetate 
52 µm 18 µm 





 Effect of Supersaturation  
In general, increasing the driving force i.e. supersaturation leads to an increase in the average 
crystal growth rates in the length and width dimensions as shown in Figure 6.8. The extent of the 
increase in growth rate is dependent on the solvent; increasing supersaturation (S-1) by 0.02 
results in an increase in average growth of both length and width directions by factor of 2.0, 1.6, 
1.5, and 3.5 for AC, MeCN, EA, and MeOH respectively. Methanol provides the largest increase 
in growth of salicylamide with respect to same increase in supersaturation in the other solvents. 
The average growth rate of the width direction in MeCN slightly decreases when increasing the 
supersaturation (S-1) from 0.025 to 0.037. Yet the maximum growth rate of SAM obtained in 
the lower and higher supersaturations were 0.19 µm/s and 0.24 µm/s respectively, proving that 
the higher driving force did in fact result in a higher growth rate for some seed crystals. 
Interestingly in the case of acetonitrile were a relatively low supersaturation of 0.012 was used, 
the average growth rate in both the length and width dimension was negligible. However, upon 
visual examination of the crystals before and after growth (Figure 6.9) under these conditions it 
is clear to see that a growth process has occurred, primarily repairing morphological defects i.e. 












































































































































Figure 6.8. Average crystal growth rate (µm/s) of both length and width plotted against 









Figure 6.9. Micrographs show a salicylamide crystal before and after growth via the rotating 







 Effect of Temperature 
The influence of temperature on the average crystal growth of salicylamide in acetonitrile is 
shown in Figure 6.10. A 10 °C increase in the temperature results in a fourfold increase in the 
average growth rate of SAM in the fastest growth direction, length. This strong dependence is of 
course reflected in the activation energies, Ea; which can be obtained by fitting eq 19 (log of eq 
16, where C is a constant as experiments were performed at the same supersaturation) to the 
average growth rates at the three temperatures, simultaneously. Ea values in the length and width 
directions are 93 kJ/mol and 96 kJ/mol, respectively.  






) + ln C       (19) 
In our previous work as outlined in chapter 4 [7], multiple salicylamide crystal seeds were grown 
simultaneously in a batch reactor using an isothermal seeded desupersaturation crystal growth 
method. Increasing temperature within the same range from 10 °C to 20 °C in MeCN also led to 
a fourfold increase in the growth rate of salicylamide and the activation energy was also found 
to be 96 kJ/mol. Despite significant differences between the two growth methods, it is of great 
reassurance that both methods estimate the same activation energy value. These activation 
energies are clearly higher than the values expected for simple molecular diffusion (5 – 20 kJmol-
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Figure 6.10. Average crystal growth rate (µm/s) of both length and width with respect to the 
crystal growth temperature (10, 15, and 25°C) for acetonitrile at initial supersaturation (S-1) of 





 Effect of the Crystal Seed Properties (Quality)   
As a retrospective analysis, the effect of the initial seed crystal quality on the salicylamide crystal 
growth rate was examined. For the purposes of this inquiry the seed crystal quality is divided 
into three categories; “high” which refers to near perfect crystals in terms of symmetric shape 
and also surface, “medium” which refer to crystals that have an issue with shape or surface and 
lastly “low” which refer to crystals that have an issue with both the shape and crystal surface. 
An example of a seed crystal from each category is shown in Figure 6.11. Initial seed crystal 
quality is found to have an impact on the crystal growth rate, with the “low” seed crystal quality 
leading to the fastest growth rates whereas “high” seed crystal quality having slower growth 
rates. This can be rationalised due to the increased number of surface defects present on the 
“low” quality crystals which can act as attachment sites for crystal growth units and so result in 
faster growth. Initial seed crystal quality plays a large effect on the growth rate dispersion (GRD) 
observed, a lower quality inherently results in wider GRD. There is an increase in the GRD by a 
factor of 2 for the “low” quality seed crystals versus the “high” quality seed crystal; 0.2 µm/s 
range versus 0.1 µm/s range respectively. Industry require a narrow GRD and so using a high 
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Figure 6.11. Comparing crystal growth rate of length (µm/s) of salicylamide in acetonitrile 
with respect to initial seed crystal quality (high, medium and low). On the right hand side of 






 Discussion  
 Comparison of the Two Single Crystal Growth Methods 
Salicylamide seed crystal growth rates obtained from the cuvette and the rotating disk 
experiments at 15 °C are compared in Figure 6.12. The cuvette growth experiments are 
performed without forced convection whereas in the rotating disk experiments there is a fairly 
controlled hydrodynamic situation in the rotation of the disk at 200 rpm. Obviously the growth 
rate is much higher in the rotating disk experiments, e.g. at (S-1) of 0.03 the average growth 
increases by a factor of 20 (0.003 µm/s versus 0.060 µm/s) for cuvette growth method and the 
rotating disk method respectively.  
Crystal growth is widely accepted to occur by two phenomena assumed to act in series; transport 
of solute through the liquid boundary layer to the crystal-liquid interface (volume diffusion) and 
integration of solute molecules into the crystal lattice (surface integration) [8-12]. With 
increasing relative velocity between the crystals and the fluid the volume diffusion resistance 
decreases. The crystal growth rate increases and the crystal growth process becomes increasingly 
governed by the surface integration step. Accordingly, it is perfectly in accordance with 
expectation that the cuvette experiments would deliver a growth rate that is equal to or lower 
than the rotating disk growth rates. The fact that there is a substantial difference reveals that at 
least the cuvette experiments are significantly influenced by the volume diffusion resistance.  
The influence of the rotation rate in the rotating disk experiments has been evaluated in the 
solvent which had the highest viscosity (Table 3.1) as the rate of diffusion is inversely 
proportional to the viscosity of the solution. Five stirring rates from 50 rpm up to 350 rpm has 
been evaluated for crystal growth in acetonitrile and the result is illustrated in Figure 6.13. Above 
150 rpm the growth rate no longer increases with increasing rotation rate. Accordingly, a stirring 
speed of 150 rpm was found to be sufficient to essentially eliminate the volume diffusion mass 
transfer resistance, and accordingly the growth experiments performed at 200 rpm can be 



















































Figure 6.12. Average crystal growth rate of the (200) face of salicylamide seed crystals grown 
in acetonitrile in supersaturation (S-1) range of 0.01 – 0.12 at 15 °C by the two crystal growth 
methods outlined in this paper. The cuvette growth method is shown as the orange triangles 
and the rotating disk growth method is shown as the purple circles. 
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Figure 6.13. Average crystal growth rate of the (200) face of salicylamide seed crystals grown 
using the rotating disk growth method at different stirring rates (50 up to 350 rpm) in 




 Comparison of Single Crystal Growth with the Multiple Crystal Growth 
Study 
In chapter 4, a batch agitated reactor was used to grow multiple salicylamide seed crystals via a 
seeded isothermal desupersaturation crystal growth method [7]. This study used the exact same 
sieve fraction 300 – 355 µm and solvents as were used in the rotating disk study, and the same 
crystal growth temperature and similar supersaturation range. The growth order parameter 
indicated that the growth process in the batch reactor was governed by surface integration. In 
Figure 6.14, these results are compared with the present rotating disk results were the crystal 
growth rate which is reported is representative of the average growth of the length and width 
dimensions as this accounts for the overall growth of the crystal and so acts as the best 
comparison with the MCG data which obtain overall crystal growth rates for the system. In all 
solvents, the magnitude of growth in the two methods is the same. In MeCN, EA and MeOH the 
growth rates are very similar, whereas in AC the growth is slightly faster in the rotating disk 
experiments. The slight variations in growth rates can be explained by the differences in the 
number of crystals involved; on average 12,000 crystals are grown simultaneously in the batch 
crystal growth study whereas the rotating disk studies only 32 crystals are grown at the same 
time. This chapter has shown that the growth rate dispersion for salicylamide crystal growth data 
is relatively wide, hence the larger sample size in the agitated reactor experiments would lead to 
better estimation of the average crystal growth rate. In addition, it should be recognised that in 
the rotating disk method the growth in a specific direction for each crystal is directly measured 
as an increase in the linear dimension, whereas in the batch reactor method the overall average 
growth rate in terms of the linear dimension used to characterise the size over all crystals is 
determined indirectly by recording the decay in solution concentration and assuming a constant 
crystal shape. Accordingly, the two methods have different merits and drawbacks and 
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Figure 6.14. Crystal growth rate of salicylamide crystals grown by two methods in the four solvents at 15°C with 
respect to supersaturation. The crystal growth rate (µm/s) for the rotating disk studies is equal to the average 
growth rate of length plus the average growth rate of width divided by two. The agitated tank crystal growth rates 





 Conclusion  
Crystal growth of salicylamide was investigated under both diffusion and surface integration 
control, and the associated growth rates were measured. The crystal growth rates of the (200) 
facet obtained under surface integration controlled growth resulted in 20 times faster growth 
rates than when grown under diffusion controlled growth. Under surface integration controlled 
growth process, when salicylamide was grown in MeOH the surface appeared to have rows of 
steps whereas when it was grown in EA the surface was comprised of a corrugated step 
appearance. Within acetonitrile, increasing temperature by 10 °C led to a fourfold increase in 
salicylamide’s growth rates in the length direction. The rotating disk method delivered growth 
rates in good agreement with our previous data obtained by isothermal seeded desupersaturation 
experiments in an agitated tank. The rotating disk method allows for a more detailed examination 
of the growth in particular directions and of particular faces, while simultaneously allowing for 
data of a number of crystals to be collected simultaneously. By changing the rotation rate the 
relative influence of boundary layer diffusion can be changed, and in the presented work 200 
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 Single Crystal Growth of Two Piracetam Polymorphs 
This chapter studied the crystal growth process and associated kinetics of multiple single 
crystals of two polymorphs of piracetam within ethanol and isopropanol using the rotating disk 
method. The crystal growth rates in the length and width direction were precisely measured in-
situ for each individual crystal; and growth rates were also extracted for a specific crystal facet 
i.e. (011). The impact of polymorph form, organic solvent, supersaturation, and temperature on 
the crystal growth of piracetam was studied. The metastable FII form was found to have faster 
growth rates than the thermodynamically stable FIII form. Within the range of experimental 
conditions, the growth kinetics of both polymorphs were strongly affected by the temperature 
and to a lesser degree by solvent choice. Ethanol provided faster growth rates than isopropanol 
for both polymorphs. The influence of the supersaturation depended on the polymorph form, 







 Results  
 Habit 
Micrographs taken before and after the growth of piracetam FIII and FII crystals in ethanol and 
isopropanol are shown in Figure 7.1. Under certain conditions, the seed crystal could grow to 
a maximum length of 1850 µm and width of 900 µm i.e. seed crystals doubled in size. FIII 
appears to have consistent growth in all directions as supported by the shape maintenance, on 
the other hand the needle FII form, especially in ETOH, appears to have enhanced growth rates 
in its width dimension which is resulting in the shape altering to a rectangle habit. This change 
in habit was due to the fact that the seed crystals were produced in a different solvent to the 
growth solvent and so the “natural” shape of the crystal was not the shape of the seed.  
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Figure 7.1. Micrographs of piracetam crystals of both polymorphs FII and FIII before and 
after growth in ETOH and IPrOH at 20 °C under supersaturation (S-1) of 0.1 for 1 hour. Only 
one representative crystal out of the total 32 crystals for each condition are shown for each in 
this image.    
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 Effect of Polymorph and Solvent  
The crystal growth rate was found to vary not only from one condition to another, but also 
among the crystals grown under the same condition, as illustrated by the error bars within 
Figure 7.2 which represent the error of standard deviation of the data. This phenomenon is 
commonly referred to as growth rate dispersion (GRD) and was observed within all conditions 
herein and also for salicylamide as discussed previously in the thesis [14]. The widest GRD 
was obtained when PCM FII crystals were grown in ethanol, crystal growth rate of the length 
ranged from 0.020 μm/s up to 0.164 μm/s among the 32 crystals examined. For both 
polymorphs, the growth rates of the length and width direction were very similar. The FII 
crystals which were manufactured in 1,4-dioxane had a needle habit which was caused by the 
stunted growth of the facets present along the width direction but when these seed crystals were 
grown further in ETOH and IPrOH the growth of the width was no longer stunted illustrating 
a strong effect of the solvent on the crystal habit. The growth rates were found to be dependent 
on the polymorph form and also on the choice of solvent as shown in Figure 7.2. The average 
growth rate of the length direction of PCM FII was 0.088 µm/s and 0.016 µm/s in ETOH and 
IPrOH respectively, whereas the growth rates for FIII in the same solvents were 0.042 µm/s 
and 0.005 µm/s respectively.  In both solvents, the metastable FII form had faster growth rates 
over the stable FIII form, 3 times faster in IPrOH and 2 times faster in ETOH. A similar increase 
in the growth rate for the metastable form versus the stable polymorph has previously been 
reported for a few other compounds [1-3] and was also found for PCM when grown using an 
isothermal seeded desupersaturation method under similar conditions [4]. Solvent choice was 
found to have a greater impact on the growth rate of piracetam than the polymorphic form, with 
the growth rates of both polymorphs being approximately 7 times faster in ETOH than IPrOH. 
PCM has previously been shown to have stronger interaction with IPrOH than ETOH which 
can explain the slower growth rates observed [15]. In chapter 5, it was shown that slower 
growth rates of salicylamide in ethyl acetate were also due to the relatively stronger interactions 
of the solvent with the solute compared to the other solvent-solute interactions [5].  
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Figure 7.2. Average crystal growth rate of (a) length and (b) width (µm/s) of piracetam FII 
and FIII polymorphs grown in two solvents (ETOH and IPrOH) at temperature of 20 °C and 
supersaturation (S-1) of 0.10. Error bars are used to illustrate the error of standard deviation 





 Effect of Supersaturation 
For both polymorphs, increasing the supersaturation i.e. driving force led to an increase in the 
crystal growth rates in both the length and width directions of the crystal as shown in Figure 
7.3. Growth rates were very similar in the length and width direction for both forms, with the 
FII form having slightly faster growth rates in the width direction particularly at the higher 
supersaturations. The extent of the increase on the crystal growth rate with increasing driving 
force was slightly dependant on the polymorph; increasing supersaturation (S-1) by +0.10 
resulted in a 2.5 increase in the growth rate for FIII whereas the increase was only by a factor 
of 2.0 for FII under the same increase in supersaturation. In the case of FIII, increasing the 
driving force also resulted in a wider growth rate dispersion. Whereas the growth rate 
dispersion remained relatively similar for FII when grown at the different supersaturations.  
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Figure 7.3. Average crystal growth rate (µm/s) of both length (filled) and width (unfilled) of 
FIII and FII polymorphs in ETOH with respect to supersaturation at 20 °C under 
supersaturation (S-1) of 0.1 for 1 hour. Error bars are used to illustrate the error of standard 
deviation of the data. 
 
  
CHAPTER 7  
116 
 
 Effect of Temperature  
The influence of temperature on the crystal growth of the two piracetam polymorphs grown in 
ethanol is shown in Figure 7.4. A 10 °C increase in the growth temperature resulted in an 
increase in the growth rate by a factor of 3.5 for FIII but only by a factor of 2.0 for FII. This 
strong dependence is of course reflected in the activation energies, Ea, which can be obtained 
by fitting eq 19 to the average growth rates at the three temperatures, simultaneously. Ea values 
in the length and width directions for piracetam FIII were found to be 88 kJ/mol for both 
directions and for FII were found to be 52 kJ/mol and 36 kJ/mol respectively. In previous work 
[4], multiple PCM FIII and FII crystal seeds were grown simultaneously in a batch reactor 
using an isothermal seeded desupersaturation (ISD) crystal growth method. Increasing 
temperature within the same range from 20 °C to 30 °C in ETOH also led to an increase in the 
growth rate by a factor of 2.0 for FII but only by a factor of 2.4 for FIII. This work also 
estimated the activation energy values for both polymorphs after growth in ethanol over a 
slightly larger temperature range of 10 to 35 °C and gave values of 65 kJ/mol and 39 kJ/mol 
for FIII and FII respectively. The ISD method assumes the growth values and thus the 
activation energy values are representative of the width direction as the original crystal size 
was determined by sieving and so represents the second largest dimension, Ea values for FII in 
the width direction are very similar from the two methods. Slightly lower activation energy 
value was calculated for FIII when using the ISD method, though both growth methods 
successfully calculate that the metastable form will have a lower activation energy. These 
activation energies are clearly higher than the values expected for simple molecular diffusion 

























































Figure 7.4. Average crystal growth rate (µm/s) of both length (filled) and width (unfilled) of 
FIII and FII polymorphs in ETOH with respect to the crystal growth temperature under 
supersaturation (S-1) of 0.1 for 1 hour. Error bars are used to illustrate the error of standard 




 Effect of the Crystal Seed Properties (Size) 
This work also examined the influence of the crystal seed properties on the crystal growth rate, 
in particular the effect of the seed size and also whether or not re-growing a seed crystal would 
result in a change of the crystal growth rate. Particle size has been shown to have an effect on 
the crystal growth kinetics. Two crystal seed sizes have been investigated in this work, 
including a smaller seed fraction of 100-180 µm and a larger seed fraction of 250-400 µm. 
Both seed sizes gave growth rates of the same order of magnitude, though it is clear to see from 
Figure 7.5 that the smaller seed size have a lower average crystal grow rate which would begin 
to suggest a size dependant crystal growth model (SDG). However when all the crystals which 
were grown were examined, it was clear that to see that the phenomenon of growth rate 
dispersion (GRD), i.e. different crystals within a population (under uniform conditions) exhibit 
a range of growth rates, is the more dominant model occurring for both seed groups as indicated 
by the overlap of the two crystal data sets. These findings are in agreement with the literature 
that the SDG is likely to be an artefact of GRD which in turn is attributed in part to the surface 
effects induced by the crystals growth history. This surface effect can be investigated by re-
growing the crystals for a second time in a new supersaturated solution. As shown in Figure 
7.6 the growth rates decreased upon re-growing despite the increase in the initial crystal seed 
size. These results support the idea that the initial growth process typically attempts to repair 
the defects within the crystal, thus leading to a smoother crystal surface which ultimately will 
result in slower growth rates during the second growth stage.  
  











0.00 0.02 0.04 0.06 0.08
0.0420.015
100-180 m 250-400 m














Figure 7.5. Crystal growth rate of length (µm/s) plotted against it’s respective crystal ID 
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Figure 7.6. Crystal growth rate of length (µm/s) plotted against it’s respective crystal ID 
number. Crystals were grown initially for 1 hour (circle points) and then placed into a new 






 Facet Growth Rates of Two Polymorphs  
So far the crystal growth of the two polymorphs has been described in terms of the length and 
width directions which are of course indicative of the crystal facets present on these sides of 
the crystal. Fundamentally it is of greater interest to express the growth rates in terms of a 
specific facet, in order to do so we must first identify the faces of the two piracetam crystal 
forms through the combined use of experimental and prediction techniques [5]. The vacuum 
growth morphology of piracetam FII and FIII was predicted using the attachment energy 
method, habits for both polymorphs are shown in Figure 7.7. FII was predicted to form a 
rectangle habit whereas FIII forms a square habit. When grown through recrystallization in a 
solvent they did in fact form a needle and rectangle habit, respectively. The two polymorphs 
have a common (0 1 1) face which grows in the width direction for FII and in the length 
direction for FIII and so will be used to compare facet growth rates for the two polymorphs. 
The (0 1 1) facet of the experimentally grown crystals was confirmed by measuring the 
interfacial angle between the facets and comparing it with the interfacial angle calculated using 
material studio software. 
Figure 7.8 shows the influence of the solvent on the growth rate of the (0 1 1) face of both 
polymorphs. The facet growth rate is taken as half of the corresponding rate of growth of the 
width (FII) and the length (FIII), respectively. Growth rate of the (0 1 1) face of both 
polymorphs was faster in ethanol than isopropanol. In both solvents the growth of FII (0 1 1) 
facet was faster than of the FIII (0 1 1) facet. In both polymorphs of piracetam, a 
centrosymmetric dimer present in the crystal lattice is attached with adjacent molecules by H-
bonding. These strong intermolecular interactions, e.g. hydrogen bonding, are thought to 
determine the growth direction for molecular crystals with higher growth rates expected for the 
hydrogen bonding directions [9-11]. The molecular chemistry of the (0 1 1) facet for both 
polymorphs is shown in Figure 7.9 with both showing a capability to form hydrogen bonds. 
The carboxylate and amino groups which are involved in the dimer formation are embedded 
deeper into the surface topology of the stable polymorph form in comparison with the 
metastable form and so potentially reduce the propensity for hydrogen bonding. The attachment 
energy, Eatt, of the (0 1 1) facet for FII and FIII was -115.14 kJ/mol and -220.29 kJ/mol 
respectively. This refers to the energy released on attachment of a growth slice to that growing 
crystal surface, were a lower attachment energy would result in a faster growth which is in line 
with the findings in this work.  





Figure 7.7. The growth morphology (computational attachment energy prediction, 
COMPASS-II force-field) of piracetam (a) FII and (b) FIII crystal. Miller indices are given 
for major faces.   
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Figure 7.8. Average crystal growth rate of the (011) face (µm/s) piracetam FII and FIII 
polymorphs grown in two solvents, ETOH and IPrOH, at 20 °C under S-1 of 0.10. Error bars 
are used to illustrate the error of standard deviation of the data. 
 
  









Figure 7.9. Molecular representations of the (011) crystal face of piracetam FII and FIII 
polymorphs. An arrangement of H-bonds (black dots) in the crystal structure of piracetam FII 
and FIII polymorphs. Highlighted is the piracetam dimer. Hydrogen – white, carbon – grey, 
oxygen – red, nitrogen – blue. 
 




 Comparison of Single Crystal Growth with the Multiple Crystal 
Growth Study  
In previous work [4], a batch agitated reactor was used to grow multiple PCM FII and FIII seed 
crystals via an isothermal seeded desupersaturation crystal growth method. This method used 
the smaller seed size (sieve fraction 100–180 µm). Aside of this all other experimental 
considerations (such as solvents, temperature and supersaturation range) were the same. The 
growth order parameter indicated that the growth process in the batch reactor was governed by 
surface integration. In Figure 7.10, these results are compared with the present rotating disk 
results. Overall, both growth methods in spite of significant differences in the hydrodynamics 
resulted in quite similar growth rates of the two piracetam polymorph crystals when grown 
under same conditions, the magnitude of growth was the same. In the previous work it was 
concluded that surface integration was the limiting step. In the present study, this could be 
experimentally verified by altering the rotation rate. With increasing relative velocity between 
the crystals and the fluid the volume diffusion resistance should decrease. The crystal growth 
rate increases and the crystal growth process becomes increasingly governed by the surface 
integration step. Four stirring rates from 50 rpm up to 300 rpm were evaluated for the crystal 
growth of the stable form in ethanol and the result is illustrated in Figure 7.11. Above 200 rpm 
the growth rate no longer increases with increasing rotation rate, the volume diffusion mass 
transfer resistance has been reduced to the extent where growth is governed by surface 
integration. The diagrams in Figure 7.10, indicate that there may be a mechanism transition 
occurring within the range of supersaturation. It is clearer for the FII form at about S-1 equal 
to ~0.08, but perhaps also occurring for the FIII form at S-1 equal to ~0.15, there is a change 
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Figure 7.10. Crystal growth rate of piracetam FIII & FII crystals grown by two methods in 
ethanol at 20 °C with respect to supersaturation. The crystal growth rate (µm/s) for the 
rotating disk studies is equal to the average growth rate of length plus the average growth rate 
of width divided by two. The agitated tank crystal growth rates are obtained from a previous 
study [4]. 
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Figure 7.11. Average crystal growth rate of width (µm/s) of PCM FIII grown using the 
rotating disk growth method at different stirring rates (50 to 300 rpm) in ETOH with 
supersaturation (S-1) of 0.1 at 20 °C. 
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 Conclusion  
Crystal growth of piracetam FII and FIII polymorphs was investigated under a surface 
integration controlled crystal growth process, and the associated growth rates were measured. 
The rotating disk growth method utilised in this work allowed for the hydrodynamic 
environment to be controlled, yet also track multiple single crystals for their specific facet 
growth rates at once. The growth rates obtained using this rotating disk method compared well 
with previously published growth data of the same compound which used a more traditional 
isothermal seeded desupersaturation growth method. The metastable polymorph, FII, was 
found to have growth rates which were double than the rates obtained for the stable form, FIII. 
The crystal growth rate of the (0 1 1) facet had growth rates which were 7 times faster when 
grown in ethanol than in isopropanol, as explained by piracetam having stronger interaction 
with the latter solvent. Increasing temperature by 10 °C led to an increase in growth rates of 
FIII and FII by a factor of 3.5 and 2 respectively. Increasing supersaturation by S-1 of 0.10 
doubled the growth rates of the two polymorphs. The findings show that the two polymorph 
crystals grew at different rates under the same conditions and were also affected to different 
extents by the various experimental conditions tested which highlights the importance of 
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 General Conclusions & Future Directions 
The objective of this thesis was to attempt to rationalise the crystal growth process, in particular 
to understand the kinetics. The ultimate aim was to try to make the pharmaceutical 
crystallisation process more robust and reliable and in the future predictable. The crystal 
growth process, and associated kinetics, of salicylamide (SAM) and two polymorphs of 
piracetam (PCM FII/ FIII) was successfully investigated in this work. The multiple crystal 
growth study which used the isothermal seeded desupersaturation method studied the growth 
of thousands of SAM crystals at once under controlled hydrodynamic conditions and so 
provided a statistically relevant analysis of the growth process. The single crystal growth 
studies that used the cuvette method allowed the growth of SAM to be investigated at a 
fundamental level by observing the growth rate of specific crystal facets. The single crystal 
growth studies which used the alternative rotating disk growth method allowed the growth of 
32 seed crystals of SAM and separately PCM FII/ FIII to be observed at a fundamental level 
but also under controlled hydrodynamics.  
By comparing the growth data of salicylamide obtained from the two single crystal growth 
methods when grown under the same experimental conditions the hydrodynamics were found 
to have a significant impact on the crystal growth process. The growth rate of the (200) facet 
was increased by a factor of 20 when using the rotating disk method compared to the cuvette 
method, the addition of sufficient rotation was found to alter the growth process from volume 
diffusion resistance controlled growth to surface integration controlled growth. It should be 
highlighted that single crystal growth studies reported in the literature which used the cuvette 
method are thus likely to provide diffusion controlled kinetic data. As the rotating disk method 
was controlled by the surface integration step, the kinetic data obtained for both SAM and PCM 
was compared with the isothermal desupersaturation crystal growth method (multiple crystal 
growth) as this also provided surface integration controlled growth data. For both API, the 
rotating disk method delivered growth rates in good agreement with the data obtained by the 
multiple crystal growth experiments in spite of significant differences in the methodology 
which is very promising.  
The effect of several process conditions on the crystal growth process of SAM and PCM FII/ 
FIII was resolved e.g. seed, temperature, supersaturation, and solvent. From the single crystal 
growth studies of SAM, cuvette method the use of seeds was found to control the crystal habit 




nucleated crystals. Within the seeded single crystal growth studies of SAM and PCM, which 
used the rotating disk method, a lower seed quality and larger seed size were found to increase 
the growth rate and the growth rate dispersion. Furthermore, the PCM studies concluded that 
the seed polymorph form impacted the resulting crystal growth rates with the metastable 
polymorph, FII, having growth rates which were double that of the rates obtained for the stable 
form, FIII. Increasing temperature by 10 °C was found to increase the growth rates of both 
SAM and PCM FII and FIII by a twofold increase in most cases, however a fourfold increase 
was found for SAM when grown in acetonitrile. Although the reason for this significantly 
higher increase in acetonitrile is still not understood, the effect of temperature on the growth 
of both API in the respective solvents was the same when grown using both the single crystal 
growth method (rotating disk) and multiple crystal growth method (isothermal seeded 
desupersaturation). Despite significant differences between the two growth methods, it is of 
great reassurance that both methods estimated similar activation energy values for SAM and 
PCM. Increasing supersaturation by S-1 of 0.10 led to a two-fold increase in the growth rates 
of both PCM polymorphs.  
Although solvent choice was found to have one of the lower impacts on the crystal growth 
kinetics of SAM, it was found to have a large impact on the resulting crystal habit when SAM 
crystals were grown via slow solvent evaporation in different solvents. This experimental and 
supporting molecular modelling work concluded that solvents which were found to have a 
higher adsorption energy with specific crystal facets of salicylamide and also have a larger 
molecular weight, such as ethyl acetate, ultimately impeded the growth of such facets and thus 
has a greater effect on the habit compared to the other solvents. Similar conclusions were drawn 
for the effect of solvent on the growth of piracetam within this work also, where a stronger 
interaction of solvent molecules with piracetam lead to reduced growth rates by a factor of 7. 
Furthermore, the use of scanning electron microscopy to examine the crystal surface of 
salicylamide after growth in a number of solvents visually confirmed that growing a solute in 
different solvents created different topographical features on the surface which also accounted 
for the slower growth rate of salicylamide within ethyl acetate compared with methanol. 
The initial step of the growth process, diffusion, is well understood in the literature, whereas 
the subsequent step, surface integration, is not. The novel single crystal rotating disk method 
developed in this thesis provides a cost effective experimental approach to study the growth of 




method provides statistically valid kinetic data obtained under surface integration controlled 
conditions. So far this method has been used to successfully study the growth of seven API 
under surface integration conditions, two compounds of which have been discussed in this 
thesis. The research reported in this thesis has only scratched the surface in this area and has 
set out an experimental method which can be used to probe and attempt to understand the 
surface integration step in more detail. A key area for future work is the application of this 
rotating disk method to a range of other API, including their polymorphs, and process 
conditions. Within this thesis, two well-known surface integration facet growth models (BCF 
and B&S) were fitted to growth data obtained from the multiple crystal growth method which 
is an overall growth rate for thousands of crystals. It would be of far greater interest to be able 
to fit these models to surface integration controlled growth data obtained for specific facets, 
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